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As the necessity to improve in vitro embryo production efficiency is ever increasing, so 
too is the prerequisite obligation to improve oocyte competence. The ability of an oocyte to 
successfully produce a viable embryo requires that it both completes meiotic maturation and 
synchronously achieves cytoplasmic competence; an encompassing term that refers to the 
oocytes correct accumulation and storage of mRNAs, proteins and factors as well as the 
development and reorganization of organelles and the cytoskeleton. The current research was 
designed to analyze those methods that go into oocyte collection and pre-maturation handling to 
determine if there are ways to ensure the cohort of oocytes being placed in in vitro maturation 
(IVM) are those with the highest potential to develop. It was found that collection during 
different phases of the follicular wave had negligible effects on oocyte competence. However 
oocytes collected from growing follicles had increased ability to respond to calcium release 
signals compared to those recovered from atretic follicles, which was found to be important for 
embryo production rates. Oocytes retrieved from post-mortem ovaries exhibited irregular gene 
expression in immature oocytes, but expression patterns were more similar to ovum pick-up 
(OPU) oocytes following IVM. However, oocytes that were recovered following super-
stimulation, while initially similar in gene expression to other recovery methods, displayed a 
dramatic increase in the level of gene transcripts present in mature oocytes. Looking only at OPU 
oocytes, incubation in meiotic delay was not only irreversible in some oocytes but was also only 
mildly successful at improving cytoplasmic maturation dynamics. Further, mitochondrial 
abnormalities in both distribution (projects 1, 2 and 4) and shape (project 4) were frequent. This 
suggests that recovering oocytes prematurely arrests mitochondrial development, which may be a 
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major factor in low embryo production rates. Current research found that oocyte pre-incubation 
is unnecessary, and that oocytes recovered from post-mortem ovaries are likely of the greatest 
developmental competence. When recovering oocytes by OPU, timing is  unimportant but super-





In vitro oocyte maturation is the process of removing an oocyte from an antral follicle, 
inducing precocious meiotic maturation and supporting this development through oocyte culture. 
Because oocytes are removed from the support and developmental signals provided by the  
follicular environment, maturation not only proceeds earlier than natural, but often involves 
irregularities that result in in vitro matured oocytes having compromised developmental 
competence (Hyttel et al., 1997; Thomas et al., 2004b). Because the organelles, proteins and 
factors present in the ooplasm are required for embryo development for the first four days, the 
limiting factor in in vitro embryo production is the intrinsic competence of the oocyte itself 
(Lonergan et al., 2000). Many of these factors are only gained through interactions with the 
follicular milieu in the final stages of oocyte development, or later during final maturation.  
As oocytes undergo meiotic maturation, they simultaneously undergo molecular changes, 
and organelle and cytoskeletal reorganization collectively termed cytoplasmic maturation. The 
successful completion of cytoplasmic maturation, although thus far difficult to measure, has been 
identified as one of the leading factors in determining if an oocyte can successfully produce 
offspring. As a result, the best practice towards improving in vitro embryo production efficiency 
is to improve our ability to both recover and mature highly competent oocytes.  
However, there is inconclusive evidence on what best practices for producing the best 
oocytes might be. Although it has been recognized that oocytes from larger follicles have 
completed a higher degree of development and so are of greater competence, there is conflicting 
evidence on the potential effects of exogenous hormones and follicular atresia on oocyte 
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competence. An improved understanding of which oocyte retrieval processes lead to recovery of 
a cohort of oocytes with the greatest cytoplasmic competence, and thus the highest probability of 
producing offspring, could be significant for improving the efficiency of reproductive 
technologies in bovines. Both researchers and the cattle industry make use of oocyte collection 
and in vitro embryo production, and improving the intrinsic competence of the oocytes used 
would only stand to increase the efficacy and ultimate usefulness of these procedures. 
In an effort to address the requirement for oocytes of optimal competence, these studies 
were designed to determine the effect of initial oocyte handling and recovery methods on oocyte 
developmental competence and on markers of cytoplasmic maturation. In the first study, oocytes 
were exposed to the cyclic adenosine monophosphate (cAMP) modulators IBMX and forskolin 
for 2 hours prior to in vitro maturation. It was found that while the pre-maturation protocol was 
successful at maintaining oocytes in meiotic arrest and at maintaining gap junction 
communication, this did not have an effect on improving either mitochondrial distribution 
characteristics of F-actin polymerization in matured oocytes. Results indicated that the meiotic 
arrest caused by cAMP modulation was not beneficial in improving cytoplasmic maturation, and 
that the meiotic arrest was partially irreversibly decreasing maturation rates rather than 
improving maturation characteristics.  
The second study was designed to determine the effect of the phase of the follicular wave 
at the time of oocyte retrieval on oocyte developmental competence and embryo production 
parameters. It was found that oocyte collection during follicular wave growth, peak, or atretic 
phases did not affect oocyte recovery rates. However, as determined by measuring inositol 1,4,5-
trisphosphate receptor 1 expression and mitochondrial location oocytes collected during follicle 
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atresia were of decreased competence than oocytes recovered during follicle growth or peak 
phases.  
Finally, in studies three and four differences in oocyte competence, as determined by 
embryo production rates, global gene expression patterns and oocyte ultrastructure, were 
assessed as functions of the method of oocyte collection. This study was designed to determine if 
oocyte recovery method plays a role in the developmental competence of oocytes used for in 
vitro embryo production. It was determined that in vitro matured oocytes collected following 
super-stimulation with exogenous follicle stimulating hormone had increased transcript 
abundance, especially in genes regulating energy production and mitochondrial structure 
compared to oocytes collected following unstimulated ovum pick-up (OPU) or those recovered 
post-mortem. Oocytes recovered following stimulation had some mitochondrial irregularities, 
which were also seen in unstimulated OPU oocytes, but had high embryo production rates 
compared to OPU oocytes indicating that the high transcript abundance was beneficial rather 
than detrimental to embryo development.  
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CHAPTER II 
REVIEW OF THE LITERATURE 
2.1 Overview 
Oocytes are produced from primordial germ cells during fetal development in cattle. 
After initial propagation, the entire cohort of oocytes is arrested within the ovary of the fetus 
throughout the remainder of gestation and pre-pubescent life. Following puberty, oocytes are 
activated in small cohorts each estrous cycle, whereupon they complete development. Within 
each estrous cycle only one follicle, containing a single oocyte, will achieve dominance, 
supporting the oocyte in completing maturation for eventual ovulation and fertilization. The 
remaining oocytes from the activated cohort will undergo atresia. 
The journey of the oocyte from stasis through to ovulation is a complex event that 
requires communication between the oocyte, the surrounding somatic cells and even factors 
found within the follicular fluid to properly coordinate the necessary steps of both meiotic and 
cytoplasmic maturation. For an oocyte to be fertile and capable of producing an embryo, it is 
essential that the proper signals be received for each of these steps to occur and for the oocyte to 
finally garner competence by the completion of maturation, at the time of ovulation.  
Oocytes used in reproductive technologies, are harvested using a variety of manners, 
most of which involve removing the oocyte from the follicular environment prior to the 
attainment of full competence. This is followed by in vitro culture under conditions that attempt 
to simulate physiological conditions but which have been found to fall short of fully supporting 
the cytoplasmic changes necessary in attaining full developmental potential. Because so much of 
embryo developmental rates are based on the oocyte’s competence, research has been focused on 
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methods of recovering those oocytes most likely to have attained a degree of competence that 
would allow them to complete maturation and prevail in current in vitro maturation conditions. 
2.2 In Vivo Oocyte Development and Folliculogenesis 
Oocyte development, or oogenesis, begins in the fetus. In cattle this first occurs at 
approximately day 82 of gestation (Bilodeau-Goeseels, 2012), but the journey of oocyte 
development and maturation is not completed until after fertilization occurs in the adult animal. 
Oocytes are the gametes found in all female animals originating from primordial germ cells 
derived from the epithelium of the yolk sac (Byskov, 1986). Once established in the primitive 
ovary of the fetus, the oogonia undergo many rounds of mitotic division, multiplying to produce 
the animal’s entire lifetime supply of gametes. Following multiplication, they differentiate and 
enter meiosis, after which they are termed primary oocytes. Primary oocytes undergo meiotic 
arrest at the dictyate stage of prophase one, which is maintained throughout the remainder of 
fetal development, and the animal’s life until just prior to ovulation, when meiotic resumption 
occurs. Oocytes arrested in the dictyate stage are referred to as being in the germinal vesicle 
stage, as the nucleus is still compact and contained within a nuclear membrane.  
Even before final maturation begins, oocytes gradually and sequentially acquire the 
capacity to mature, become fertilized and to support early embryonic development, throughout 
the oocyte growth phase (Eppig et al., 1994; Mermillod et al., 1999; Brevini Gandolfi and 
Gandolfi, 2001; Krisher, 2004; Hussein et al., 2006; Sirard et al., 2006a). Oocyte growth is 
largely controlled by interactions between the oocyte, granulosa cells, and factors found within 
the follicular fluid (Reader et al., 2017). Oocyte growth begins in primordial follicles and ends 
prior to ovulation, with the initiation of maturation. During this time they undergo many changes 
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necessary for supporting oocyte activation and early embryonic development including; 
organelle replication and accumulation of proteins and RNAs (Fair et al., 1997; Swain and Pool, 
2008). For this reason, oocytes recovered from larger follicles are more fully developed and 
more competent to produce embryos (Blondin and Sirard, 1995; Hagemann, 1999). Alternately, 
oocytes from prepubertal animals have not received adequate support from follicular fluid, or 
granulosa cells to stimulate growth, and as a result even those oocytes harvested for in vitro 
maturation have poor developmental competence when recovered from prepubertal animals 
(Armstrong, 2001; Reader et al., 2017).  
The granulosa cells directly surrounding the oocyte take on special functions, involving 
many close interactions with the oocytes, and are referred to as cumulus cells (CCs). Cumulus 
cells have significant influence on oocyte development through the supply of nutrients and small 
molecules involved in regulating oocyte meiotic maturation and metabolism (Chian and Sirard, 
1995; Dunning et al., 2015; Brown et al., 2017). Cumulus cells are also responsible for 
delivering cytoplasmic signaling molecules that are necessary for oocyte development, for 
inducing sperm penetration and capacitation (Brown et al., 2017) (Dode and Graves, 2002) and 
for regulating the diffusion of metabolites and nutrients from the surrounding milieu into the 
oocyte (Dunning et al., 2012). Communication is bi-directional between CCs and the oocyte 
through gap junctions, a type of trans-membrane channel. This communication also plays an 
active role in controlling CC function, growth, differentiation and metabolism through release of 
oocyte secreted factors (Gilula et al., 1978; Gilchrist et al., 2004; Krisher, 2004; Thomas et al., 
2004b; Hussein et al., 2006; Gilchrist and Thompson, 2007). Either removal of the cumulus cells 
or the disruption of their communication with the oocyte prior to completion of maturation has a 
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significant effect on decreasing the developmental competence of the oocytes (Zhang et al., 
1995; Fatehi et al., 2002; Gilchrist and Thompson, 2007; Brown et al., 2017). 
Because of the importance of cumulus cells in regulating oocyte development, one of the 
best indicators of oocyte competence is the presence of cumulus cells completely surrounding 
the oocyte. Oocytes recovered with few to no associated cumulus cells have a significantly 
decreased chance at normal maturation and fertilization (Shioya et al., 1988). Oocytes with few 
cumulus cells are most frequently recovered from large follicles, which is believed to be 
indicative of follicular atresia (Fukui and Sakuma, 1980). However, even in cumulus-oocyte 
complexes (COCs) with a normal cumulus cell investment, the connection between the oocyte 
and cumulus cells changes as maturation proceeds, in fact is necessary for maturation completion 
(Larsen et al., 1986). As meiotic maturation advances, the gap junctions permitting 
communication between the oocyte and cumulus cells are broken down, severing the connection 
completely by 13 to 24 hours in IVM, before the oocyte reaches metaphase II (Hyttel, 1987). 
This gap junction breakdown is critical for successful maturation, as cumulus cells produce and 
secrete meiosis arresting factors and when the oocyte fails to receive these signals meiotic 
maturation resumes. Throughout oocyte growth, factors found within follicular fluid and 
cumulus cells maintain the oocyte in a state of meiotic arrest. Immediately prior to ovulation, the 
luteinizing hormone surge causes an increase in secretion of epidermal growth factor-like 
peptides from mural granulosa cells (Leibfried-Rutledge et al., 1987; Bilodeau-Goeseels, 2012). 
These factors stimulate the oocyte to resume meiosis and undergo meiotic maturation in 
preparation for fertilization (Gilchrist and Thompson, 2007; Bilodeau-Goeseels, 2011).  
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While oocytes are maintained in meiotic arrest, in prophase I, throughout the entirety of 
growth and development, oocyte maturation is primarily characterized by their release from 
meiotic arrest. At this point, oocytes resume meiosis, progressing to metaphase II where a second 
arrest occurs until fertilization and activation takes place to stimulate the completion of the 
second stage of meiosis. The primary indicator of oocytes having successfully completed 
maturation is the progression from the germinal vesicle stage to the second post-ovulatory arrest 
at metaphase II, following extrusion of the first polar body. Based on the ease of polar body 
identification and the absolute necessity of its extrusion prior to  fertilization, this is the most 
frequently used method of identifying mature oocytes. Successful nuclear maturation requires 
formation of the meiotic spindle and centrosomal proteins to guide chromosomal segregation 
(Reader et al., 2017).  
Following ovulation and completion of maturation, meiosis is arrested a second time in 
metaphase II until the oocyte is stimulated to undergo meiotic division. This second activation is 
achieved through penetration of the oolemma with a spermatozoan and initiates activation of the 
oocyte to prevent polyspermy, and initiate meiotic completion followed by embryo development 
(Bilodeau-Goeseels, 2012).   
2.2 Cytoplasmic Maturation 
Oocyte maturation occurs in vivo in response to a surge of gonadotropins, and involves 
cytoplasmic changes in addition to the nuclear changes involved in meiotic completion (Hyttel et 
al., 1989a, b). Cytoplasmic maturation refers to the many non-chromosomal changes that occur 
within the oocyte, prior to ovulation that are necessary for the oocyte to acquire competence to 
develop to a viable embryo, primarily necessary molecular changes, and the reorganization of the 
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cytoskeleton and organelles (Ferreira et al., 2009). While cytoplasmic maturation naturally 
occurs concurrent to nuclear maturation, these processes are independent and often become 
disjointed in in vitro maturation protocols (Krisher, 2004). Markers of cytoplasmic maturation 
include; storage of mRNA, proteins, lipids and transcription factor as well as the reorganization 
of organelles (Krisher, 2004; Swain and Pool, 2008; Ferreira et al., 2009; Mao et al., 2014; 
Reader et al., 2017). As follicles grow and oocytes develop, the oocytes are highly active in 
synthesizing proteins and organelles but as the oocyte approaches ovulation, the oocyte reaches a 
state of quiescence (Thomas et al., 2004b). In order for an oocyte to be fully competent to 
support embryonic development, all of the necessary factors need to be in place prior to the 
completion of maturation and the achievement of oocyte quiescence (Thomas et al., 2004b).  
However, although many of the changes involved in cytoplasmic maturation have been 
identified, there are suspected others as yet undefined, and those that are recognized have proven 
difficult to define (Swain and Pool, 2008). 
2.2.1 Calcium 
Successful fertilization requires that oocytes have not only sequestered large amounts of 
calcium, but also that there be pathways in place to control calcium release (Dumollard et al., 
2007). Calcium is stored within the endoplasmic reticulum (ER) of oocytes, so proper release of 
calcium is highly reliant on changes within the ER. Oocyte maturation requires that ER not only 
relocalize to the suboolemma region, but it also requires reorganization of the ER to facilitate 
calcium signaling (Coticchio et al., 2015). Smooth ER must be in close proximity to 
mitochondria, as calcium levels within the oocyte are regulated by cross-talk between 
mitochondria and ooplasmic membranes (Nottola et al., 2016). 
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2.2.2 Cortical Granules 
Cortical granules are produced from the Golgi complex during oocyte growth, and 
develop as secretory organelles whose primary role is in preventing polyspermic fertilization 
(Cran et al., 1980; Abbott and Ducibella, 2001). In immature oocytes, the cortical granules are 
found randomly dispersed primarily within the most central regions of the cytoplasm (Hosoe and 
Shioya, 1997; Coticchio et al., 2016). As oocytes mature, these relocate first to clusters near the 
oocyte periphery (Kafi et al., 2005) and later to become concentrated directly below the 
oolemma, in one or two continuous rows (Cran et al., 1980; Szollosi et al., 1988; Hosoe and 
Shioya, 1997; Petr et al., 2001; Coticchio et al., 2015, 2016; Nottola et al., 2016). This migration 
is mitigated by micro-filaments within the cytoskeleton (Connors et al., 1998; Liu et al., 2010). 
As maturation proceeds, cortical granules also increase in quantity, size and density (Kafi et al., 
2005). When oocytes are fertilized, the consequent increase in calcium stimulates exocytosis of 
the cortical granules, which then release their contents, stimulating oolemma hardening and 
preventing polyspermic fertilization (Cran et al., 1988; Kline and Kline, 1992; Coticchio et al., 
2015).  Abundance of cortical granules in mature oocytes is thus important in ensuring successful 
monospermic fertilization and oocyte activation. 
2.2.3 Mitochondria 
Mitochondria, are the organelle that perhaps undergo the most notable change as 
maturation proceeds. Oocyte developmental competence is highly reliant not only on the number 
of mitochondria present, but also on the mitochondrial membrane potential and their distribution 
throughout the ooplasm (El Shourbagy et al., 2006; Tarazona et al., 2006; Van Blerkom, 2009; 
Reader et al., 2015). Those oocytes with increased numbers of mitochondria, and mitochondria 
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with increased membrane potential are considered to be more competent. Uniform mitochondrial 
distribution within the ooplasm further increases embryo production potential (El Shourbagy et 
al., 2006; Tarazona et al., 2006; Van Blerkom, 2009). While mitochondria should be found 
evenly distributed throughout the ooplasm, they do tend to be concentrated somewhat more 
heavily in areas where high levels of energy (ATP) or calcium signaling are necessary (Campello 
et al., 2006; Reader et al., 2017). As part of energy production requirements, and facilitation of 
transporting fatty acids into mitochondria for beta-oxidation, mitochondria are often found co-
located with lipid droplets in highly competent oocytes (Warzych et al., 2017).  
In the immature oocyte, mitochondria are spherical in shape with few cristae, 
representing an inactive form (Cran et al., 1980; Fair et al., 1997; Reader et al., 2017). Many 
mitochondria exhibit unique shapes, wherein they may appear to be hooded or vacuolated(Cran 
et al., 1980; Fair et al., 1997; Hyttel, 2011; Reader et al., 2015, 2017). Mitochondria are 
primarily found in peripheral regions in immature oocytes and migrate to become evenly 
distributed within the ooplasm, and commonly associated with smooth endoplasmic reticulum in 
fully matured oocytes (Cran et al., 1980; Cran, 1985; Hyttel et al., 1986; Reader et al., 2015). 
Hooded mitochondria are generally believed to be in a state of inactivity. These are found 
commonly in oocytes of sheep and cattle during later stages of oocyte growth and in increasing 
frequency as maturation proceeds (Cran et al., 1980; Fair et al., 1997; Reader et al., 2015). 
However, other studies have shown that overall mitochondrial activity and ATP production 
increase as oocyte maturation proceeds (Stojkovic et al., 2001; Tarazona et al., 2006; Abdoon et 
al., 2011; Matchatkova et al., 2012; Gutnisky et al., 2013). Mitochondrial ATP production 
decreases following oocyte growth completion in germinal vesicle stage oocytes, and increases 
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again by the time oocytes reach metaphase two (Nagano et al., 2006; Abdoon et al., 2011). Those 
mitochondria aggregated with smooth endoplasmic reticulum (SER) are more active, than those 
that are isolated and it is understood that mitochondria-SER aggregates are not only key to 
regulating ATP production but also free calcium levels (Nottola et al., 2016). 
While the change in mitochondrial location and activity with oocyte maturation are 
essential for competence, there is little to no change in mitochondrial numbers as maturation 
proceeds (Barritt et al., 2002; May-Panloup et al., 2005; Clarke, 2012; Cotterill et al., 2013). 
Mitochondrondrial replication occurs during oocyte growth and should be completed before 
antral follicle development, and final oocyte maturation (Piko and Taylor, 1987; Thundathil et 
al., 2005). However, mitochondrial copy number is an important indicator of oocyte 
developmental competence, with oocytes containing more copies of mitochondrial DNA, and 
thus more mitochondria, having higher developmental competence (Barritt et al., 2002; May-
Panloup et al., 2005; Clarke, 2012; Cotterill et al., 2013). 
Overall; the redistribution of mitochondria, and their activation to ensure ATP production 
and energy accumulation are necessary for oocyte activation and for successful embryo 
development (Thompson et al., 2000; Luberda, 2005; Gasparrini et al., 2006). 
2.2.4 Gene Expression, Protein and Factor Accumulation 
Although it is well recognized that gene expression changes as oocytes progress through 
maturation, there is not currently a clearly defined set of genes whose expression is required for 
oocyte competence (Brevini et al., 2007; Labrecque and Sirard, 2014). However, it is widely 
accepted that the acquisition of developmental competence requires that oocytes produce and 
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store the mRNAs and proteins necessary for early embryonic development, prior to the 
completion of maturation.  
As oocytes grow and mature, they produce a large quantity of a set of factors referred to 
as ‘oocyte secreted factors’ (OSFs). These OSFs, including growth differentiation factor-9 
(GDF-9) and bone morphogenetic protein-6 (BMP-6), are critical to oocyte competence as they 
regulate a broad spectrum of cumulus cell functions including; growth, survival, steroidogenesis 
and metabolism (Gilchrist et al., 2004; Bilodeau-Goeseels, 2012). Through controlling functions 
of the cumulus cells, OSFs indirectly control the viability and competence of the oocyte as well.  
2.2.5 Other Cytoplasmic Factors 
Oocyte maturation also requires changes in many other factors in order for embryonic 
development to occur. Included amongst these are production of adequate ATP and redox 
homeostasis (Dumollard et al., 2007). 
Energy production is also critical to oocyte developmental competence. Oocytes of 
greater developmental competence, have increased glucose metabolism rates, through both 
glycolysis and the pentose phosphate pathway (Sutton-McDowall et al., 2006). This is 
particularly true of mature oocytes, and it is common to find higher levels of ATP and lower 
concentrations of glutathione in metaphase II oocytes than in germinal vesicle (GV) stage 
oocytes (Abdoon et al., 2011). Meanwhile, glycolytic deficiencies have been shown to have a 
negative effect on oocyte developmental potential (Brown et al., 2017).  Oocytes are extremely 
active, producing energy while undergoing growth. As they complete growth, energy production 
decreases. One method that this is visualized is as a decrease in glucose-6-phosphate 
dehydrogenase activity (El Shourbagy et al., 2006). 
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Mammalian oocytes contain high quantities of stored lipids, used for β-oxidation and 
energy production (Dunning et al., 2010; Reader et al., 2017). To ease fatty acid transport for β-
oxidation, mitochondria and lipid droplets are often found co-located in highly competent 
oocytes (Reader et al., 2017). As such, lipid droplets are commonly found in a relatively 
peripheral orientation in immature oocytes, and become more evenly distributed throughout the 
ooplasm as maturation proceeds (Jeong et al., 2009). Lipids appear dark on a light microscope, 
and an oocyte containing a large volume of homogeneously distributed lipid should thus have an 
evenly dark cytoplasm (Jeong et al., 2009; Reader et al., 2017). Because lipidation is an indicator 
of oocyte competence, gross cytoplasm appearance is often used as a simple method of 
estimating oocyte developmental competence (Jeong et al., 2009).  
Oocytes also contain a large number of vesicles, occupying 15-35% of the cytoplasm 
(Cran, 1985; O’Brien et al., 1996; Reader et al., 2015). As maturation proceeds, vesicles increase 
in size and are found in increasingly large groups along with those mitochondria not at the 
immediate oocyte periphery (Kafi et al., 2005). However, overall vesicle volume tends to 
decrease as oocytes mature, possibly due to the oocyte metabolizing the vesicle content 
throughout maturation (Auclair et al., 2013). Due to the large volume that they occupy, vesicles 
are found approximately evenly distributed throughout the entire ooplasm with the exception of 
the most peripheral regions in immature oocytes (Reader et al., 2015). As maturation proceeds, 
vesicles migrate to a more peripheral distribution (Pederson et al., 2016). On transmission 
electron microcopy, these vesicles appear translucent, but may contain membranous material, in 
addition to large quantities of metabolites used in oocyte maturation and embryonic development 
(Reader et al., 2017). As such high quantities of vesicles in immature oocytes are necessary for 
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competence, while lower vesicle volume following maturation indicates a metabolically active 
oocyte of high developmental competence.  
Vacuoles, on the other hand, are rare or entirely absent in competent mature oocytes, and 
when identified are found to be empty but associated with lysosomes (Coticchio et al., 2016; 
Nottola et al., 2016). These are likely derived from swelling of Golgi and SER membranes and 
by cytoskeletal defects (Sathananthan et al., 1987; Nottala et al., 2008). In human oocytes, high 
numbers of vacuoles have been correlated with early degeneration and oocyte aging and is 
associated with failure of fertilization in vitro (Nottala et al., 2007, 2008, 2009; Coticchio et al., 
2010; Bianchi et al., 2014; Nottola et al., 2016).   
In general, the ooplasm of highly competent oocytes should be relatively homogenous, 
and organelles not mentioned above should be evenly distributed throughout (Shahedi et al., 
2013; Nottola et al., 2016). The oolemma is continuous, with numerous long microvilli 
projecting into the perivitelline space in highly competent oocytes (Shahedi et al., 2013; Nottola 
et al., 2016). As maturation proceeds, the perivitelline space becomes larger, and the microvilli 
both increase in number and change shape to become longer and thinner (Kafi et al., 2005). 
Cytoskeletal microtubules are distributed in a largely uniform manner throughout the cytoplasm 
of the oocyte at GV, and micofilaments are sparsely scattered (Sun and H, 2006). Following 
maturation, both microfilaments and mirotubules are primarily found in the cortical regions of 
the cytoplasm (Sun and H, 2006; Verlhac, 2011).  The redistribution of these cytoskeletal 
polymers is critical for oocyte competence as they are both involved in maintaining oocyte 
structure and, microtubules are involved in mediating the relocalization of other organelles while 
microfilaments play a key role in chromosome migration and polar body extrusion (Sun and H, 
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2006). Finally, oocytes that have a greater diameter are believed to be more competent, as this 
indicates that they are further through the growth phase and are more likely to have undergone 
the above listed changes that occur during this phase (Fair et al., 1995).  
Table 2.1. Summary of organelle features in highly competent oocytes. Adapted from (Ferreira 
et al., 2009; Mao et al., 2014; Reader et al., 2017). 
2.3 Oocyte Retrieval Methods 
In the cattle industry there are multiple methods of retrieving oocytes from follicles, each 
with its own set of benefits and drawbacks. The two primary methods of oocyte collection can be 
differentiated based on whether the donor cow is living or not. Oocytes can be recovered by 
either scraping or aspirating follicles from ovaries that are collected within the first four hours 
post-mortem (Blondin and Sirard, 1995). Since cattle are slaughtered for meat regularly, and ~20 
to 60 oocytes can be recovered from a single ovary, these make a reliable method of retrieving 
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large numbers of oocytes with minimal cost compared to other oocyte collection methods 
(Hamano and Kuwayama, 1993). However, the greatest drawback is that collection can only be 
performed on either termination or ovariectomy of the cows, and so is a single opportunity per 
animal. While post-mortem ovary harvesting can provide a reliable supply of oocytes for 
research, where genetics are relatively unimportant, or as a last-ditch effort to recover gametes 
from an individual, this is not an ongoing opportunity to produce increased offspring from 
females of genetic merit. As a result, abattoir-derived oocytes are commonly used in research but 
are only rarely applicable to commercial cattle production systems.  
Of use for more applications where individual genetic input is important, oocytes can also 
be collected from live animals, using a technique called ovum pick-up (OPU). This has the 
increased cost of maintaining the cows, but the advantage that oocytes can be harvested as 
frequently as twice weekly throughout much of the cows adult lifespan, with an average of five 
oocytes recovered per ovary (Broadbent et al., 1997). Because of this, this method of oocyte 
collection is commonly used to increase the number of offspring generated from genetically 
valuable females. In many species, live animal oocyte recovery requires that, at the least 
invasive, a laparoscopic surgery be performed to access the ovaries and aspirate follicles. 
However, the large size of cattle, permitted the design of a transvaginal oocyte collection 
technique, termed transvaginal ultrasound-guided oocyte aspiration (TUGA) , in the late 1980s 
(Pieterse et al., 1988). Using this method, ovaries are grasped transrectally, and held in place 
against the vaginal wall. An ultrasound probe, fitted with an aspiration needle, is inserted 
vaginally and used to visualize and aspirate antral follicles. Oocytes are aspirated along with the 
follicular fluid (Pieterse et al., 1988; Looney et al., 1994; Hasler et al., 1995).  
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2.4 In Vitro Oocyte Maturation 
In vitro maturation is the process of removing germinal vesicle stage oocytes from the 
follicular environment prior to the luteinizing hormone surge initiating maturation. Oocytes are 
instead incubated in a laboratory to facilitate the completion of maturation. This is becoming 
increasingly common, both in research and in reproductive assistance for human fertility and that 
of many animal species, as it is the first step in production of embryos in vitro. There are two 
primary ways in which in vivo and in vitro oocyte maturation differ;  
1. Cumulus-oocyte-complexes (COCs) used in IVM are often collected from mid-
sized antral follicles, at an earlier stage of development than they would naturally be ovulated.  
2. Having been removed from the follicular environment, COCs used in IVM are 
removed from natural meiosis inhibiting factors and spontaneously resume meiotic maturation, 
independent of a gonadotropin surge and despite potentially not having completed cytoplasmic 
maturation (Gilchrist and Thompson, 2007; Bilodeau-Goeseels, 2012). 
This issue becomes particularly apparent in oocytes collected from small to mid-sized 
follicles (2-6mm), which would naturally remain in meiotic arrest for another four days, while 
continuing to undergo cytoplasmic changes necessary to support development, before the follicle 
would become pre-ovulatory and a gonadotropin surge would occur to stimulate in vivo 
maturation (Bilodeau-Goeseels, 2012). Oocytes recovered from mid-sized to larger follicles have 
had more time to receive necessary developmental cues and are more likely to be of higher 
competence than those recovered from small follicles (Pavlok et al., 1992). 
Current IVM culture media, while complex, is not an optimal media to simulate follicular 
fluid, and is instead based off of somatic cell culture media (Gilchrist and Thompson, 2007). The 
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composition of IVM media, and thus the environment that these oocytes are exposed to, is 
significantly different from the fluid environment oocytes would naturally be maturing in within 
follicles (Sutton et al., 2003; Sutton-McDowall et al., 2005; Gilchrist and Thompson, 2007; 
Salhab et al., 2013). These environmental differences caused by IVM media shortcomings, are 
one factor driving the often reported decreased developmental competence seen in in vitro 
matured oocytes compared to their in vivo matured counterparts (Greve et al., 1987; Rizos et al., 
2002; Sutton et al., 2003; Thompson, 2006; Phongnimitr et al., 2013).  
An optimal media has not yet been devised, and as a result there are many variations on 
the market in which to mature oocytes. However, all contain the same base constiuents; a 
balanced salt solution to maintain appropriate osmolality between 265 to 300 mOsmol(Wright 
and Bondioli, 1981; Rosenkrans et al., 1993), amino acids, a pH buffer system to maintain 
consistent pH of 7.2 to 7.4, and an energy source; most commonly pyruvate, all in a purified 
water base. Bovine COCs are placed in the desired balanced oocyte maturation medium, and 
using current protocols are cultured for 18-24 hours before maturation can be expected (Ward et 
al., 2002; Lequarre et al., 2005; Agung et al., 2006). Oocytes are cultured in a humidified 
incubator at internal body temperature (38.5°C) and a low pCO2 environment (~5%), and low 
pO2 (5-7%) to simulate the anticipated conditions within the ovary (Thompson et al., 1990). 
Under normal, in vitro, conditions meiotic maturation is completed with the oocyte reaching 
metaphase II by 18 to 24 hours of culture, and it can be expected that 80% of cultured oocytes 
will successfully complete maturation (Suss et al., 1988; Sirard et al., 1989). However, overall in 
vitro matured oocytes are noted to be less competent than those produced in vivo, with decreased 
embryo production rates resulting (Rizos et al., 2002; Krisher, 2004; Walls et al., 2012, 2015). 
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Ultrastructural comparisons between in vivo and in vitro matured oocytes show general 
similarity (Coticchio et al., 2016), but it is not uncommon to find abnormalities in oocyte 
maturation, due to IVM, especially in indicators of cytoplasmic maturation and oocyte 
competence. IVM oocytes frequently exhibit aberrations in mitochondria-smooth endoplasmic 
reticulum (SER) aggregates, with mitochondria being found isolated or in association with the 
oocyte membrane rather than in close proximity to SER (Coticchio et al., 2016). In vitro matured 
bovine oocytes tend to have decreased lipid levels compared to in vivo matured oocytes (Auclair 
et al., 2013; Warzych et al., 2017). Although the number of mitochondria do not generally differ 
between in vivo and in vitro matured oocytes (Coticchio et al., 2016), IVM oocytes often show 
aberrations in the mitochondrial distribution, with increased probabilities of mitochondrial 
clustering throughout the ooplasm (Abdoon et al., 2011). It is probable that one reason for these 
abnormalities found in in vitro matured oocytes, is due to irregularities in cumulus cell function, 
resulting in oocyte exposure to dysregulated metabolites and signaling molecules during 
maturation (Brown et al., 2017). 
Although IVM has not yet been optimized for cytoplasmic maturation, parameters for 
meiotic maturation are well known. Within 16-20 hours of IVM most oocytes will reach 
metaphase II (Lequarre et al., 2005; Agung et al., 2006). When the IVM culture period exceeds 
20-24 hours oocyte competence is decreased, resulting in impaired development and decreased 
embryo production rates (Ward et al., 2002; Lequarre et al., 2005; Agung et al., 2006).  However, 
so long as the maturation period is within this critical range, oocyte competence is not hindered 
and oocytes collected during a single OPU session can be fertilized together, despite the potential 
for oocytes having matured at different times (Merton et al., 2012). Still, with current practices, 
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although IVM increases the number of oocytes that can be recovered and fertilized, only a small 
portion of those oocytes that mature to metaphase two have the potential to produce fully 
competent embryos (Schroeder and Eppig, 1984). 
2.5 Advancing Technologies in Oocyte Maturation 
Studies attempting in vitro fertilization (IVF) in cattle began in the 1970s (Sreenan, 1970; 
Hunter et al., 1972), with the first successful bovine IVF being reported in 1977 (Iritani and 
Niwa, 1977). Progress continued rather rapidly in the initial years, and the first calf was born 
following embryo transfer of an in vitro matured oocyte in 1982 (BG et al., 1982), followed by 
continued successes throughout the 1980s (Critser et al., 1986; Hanada et al., 1986; Lu et al., 
1987). 
Based on meiotic progression, IVM rates are currently high, approaching 90% (Leal et 
al., 2012). However, with current protocols, although in vitro embryo production (IVP) does 
increase embryo production rates compared to in vivo development, IVP is still quite inefficient. 
While 30-40% of matured bovine oocytes successfully develop to the blastocyst stage in vitro 
(Lonergan et al., 2000; Bilodeau-Goeseels, 2012), only 20-30% of retrieved oocytes develop into 
highly competent, transferable embryos (Van Wagtendonk-de Leeuw, 2006). This is suggestive 
of a deficiency in the developmental competence of in vitro matured oocytes, be it an innate 
oocyte competence issue or one caused by suboptimal culture conditions (Trounson et al., 2001; 
Jurema and Nogueira, 2006).  
Regardless, in vitro oocyte maturation has the potential to be a revolutionary reproductive 
technology. This allows the female reproductive capacity to be maximized through recovering 
the entire supply of oocytes available within an ovary at any given time point (either living or 
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post-mortem) for genetic preservation, or production of multiple offspring (Gilchrist and 
Thompson, 2007). In recent years, the focus has been directed towards improving the efficiency 
of in vitro embryo production by attempting to delay meiotic maturation of oocytes, while 
allowing cytoplasmic maturation to proceed. In theory, this would result in oocytes more similar 
to those matured in vivo, and hence more developmentally competent (Wu et al., 2006). The 
primary method of delaying meiotic maturation has been through artificially maintaining high 
cAMP levels within the oocyte, blocking the pathway resulting in M phase promoting factor 
(MPF) activation, and hence reversibly preventing oocyte maturation. Meiotic resumption is 
largely controlled by the activity of M phase promoting factor (MPF), which is composed of a 
regulatory subunit; cyclin B, and a catalytic subunit; CDK1 (Bilodeau-Goeseels, 2012). Methods 
to delay maturation, look at preventing activation of MPF, through maintaining high levels of its 
primary inhibitor, cyclic adenosine monophosphate (cAMP) (Homa, 1988; Bilodeau-Goeseels, 
2012). Common methods of doing so are either the inhibition of specific cyclin-dependent 
kinases to prevent activation of oocyte MPF (Gilchrist and Thompson, 2007), or the use of 
cAMP promoting/elevating agents to similarly inhibit meiotic resumption (Sirard and First, 
1988; Bilodeau-Goeseels, 2003a, b, 2012).  Artificially elevating cAMP will temporarily block 
meiotic resumption in ungulates, and has a longer-lasting effect in mice and humans (Sirard and 
First, 1988; Thomas et al., 2002, 2004a). Cyclic AMP works by activating protein kinase A 
(PKA) when cAMP levels are high. Protein kinase A inactivates CDC25b preventing its action 
and activates WEE1B which in turn phosphorylates CDK1 and inactivates the MPF complex. 
When cAMP levels drop, PKA inactivates WEE1B, and activates CDC25b which then acts to 
dephosphorylate CDK1, activating MPF and allowing meiosis to proceed (Bilodeau-Goeseels, 
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2012). Thus, artificially maintaining high levels of cAMP will block the meiotic activation 
pathway by preventing MPF phosphorylation. Although use of cAMP, or other chemicals aimed 
at altering the above pathway to inhibit MPF, have shown success at delaying maturation, there 
has not been an associated increase in embryo production (Kulbeka et al., 2000; Lonergan et al., 
2000; Ponderato et al., 2001; Hashimoto et al., 2002; Ponderato et al., 2002). 
A second method of delaying meiotic maturation in bovine oocytes is to prevent germinal 
vesicle breakdown, through inhibition of the protein synthesis necessary for MPF activation 
(Sirard et al., 1989; Lonergan et al., 1997; Avery et al., 1998). Cyclohexamide is one such protein 
synthesis inhibitor, and is commonly and successfully used in inhibiting meiosis in oocytes 
(Kastrop et al., 1991; Saeki et al., 1997). As with cAMP, inhibition with cyclohexamide is 
reversible and oocytes will resume meiosis when they are moved to a maturation promoting 
medium free of inhibitors (Lonergan et al., 1997). Although cycloheximide has been used in the 
past to successfully delay maturation, the resultant embryo production rates are decreased 
compared to those from oocytes subjected to conventional IVM, suggesting that this treatment is 
otherwise decreasing oocyte competence (Kastrop et al., 1991; Saeki et al., 1997). 
There are three different methods of cAMP modulation in use; adenylate cyclase 
activators (Thomas et al., 2002), cAMP analogues(Homa, 1988), and phosphodiesterase 
inhibitors (Bilodeau-Goeseels, 2003a). However, research to date has been inconclusive as to the 
benefits of cAMP modulators, wether alone or in combination. Meiosis is largely only transiently 
inhibited in bovines, yet many studies continue to find insignificant differences in blastocyst 
development rates between conventionally matured oocytes and those pre-incubated for meiotic 
delay (Bagg et al., 2006, 2007; Luciano et al., 2011; Gharibi et al., 2013).  
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In regards to oocyte collection, there is also dispute as to the best method for retrieving 
oocytes of the greatest innate competence. There has been evidence from recent research that 
oocytes recovered from ovaries four hours post-mortem are of optimal competence due to early 
atretic factors (Blondin et al., 1997). Based off of this understanding, super-stimulation protocols 
currently in use, and with the greatest degree of success, rely on a 24-48 hour coasting period 
following the last follicle stimulating hormone (FSH) injection, before oocytes are recovered. 
This coasting period causes atresia to begin without progressing far enough to be detrimental to 
oocyte competence (Sirard et al., 1999).  
One of the greatest challenges in improving IVM is to first improve our understanding of 
oocyte cytoplasmic maturation in order to best determine which factors are most influential on 
oocyte competence (Gilchrist and Thompson, 2007). From there, being able to collect and 
mature oocytes with the greatest degree of competence would be making great strides towards 
improving in vitro embryo production efficiency, and eventually applicability. The current study 
was geared towards using a variety of cytoplasmic markers to identify those oocytes of the 
greatest developmental competence, applied towards selecting between different oocyte 




THE EFFECT OF DELAYING MATURATION ON BOVINE OOCYTE 
CYTOPLASMIC MATURATION 
3.1 Introduction 
One of the biggest failings of in vitro maturation is that oocytes are released from 
follicular fluid, and the natural meiotic inhibiting factors found within, prior to completion of 
development. This induces oocytes to undergo spontaneous meiotic maturation without first 
accumulating all of the cytoplasmic factors necessary to sustain early embryonic development 
(Pincus and Enzmann, 1935; Edwards, 1965). Exacerbating this issue is the fact that while 24-
hour maturation is designed to promote nuclear maturation (Merton et al., 2012), conditions are 
still sub-optimal for cytoplasmic maturation completion (Hagemann, 1999). Because an oocyte 
cannot be held in the mature state without risking degeneration, there has been an emphasis on 
research into methods for temporarily inhibiting spontaneous meiotic maturation, allowing 
cytoplasmic maturation to proceed and “catch up” first. It is believed that doing so will allow 
oocytes more time in communication with cumulus cells to accumulate and store molecules 
necessary for embryonic development, before meiotic maturation resumes and the connections 
are broken (Bilodeau-Goeseels, 2012). However current knowledge of how of how meiotic arrest 
is maintained in vivo is limited and so methods in vitro are based on delaying meiotic resumption 
instead (Bilodeau-Goeseels, 2011). 
There are three different methods of cAMP modulation in use; adenylate cyclase 
activators (eg; forskolin) (Thomas et al., 2002), cAMP analogues (eg; dibutyryl cAMP) (Homa, 
1988), and phosphodiesterase inhibitors (eg; 3-isobutyl-1-methylxanthine) (Bilodeau-Goeseels, 
2003a). However, research to date has been inconclusive as to the benefits of cAMP modulators. 
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While meiosis is only transiently inhibited and gap junctional communication is maintained, 
theoretically supporting cytoplasmic maturation, studies continue to find insignificant differences 
in blastocyst development rates between conventionally matured oocytes and those pre-incubated 
for meiotic delay (Bagg et al., 2006, 2007; Luciano et al., 2011; Gharibi et al., 2013). 
One current practice, referred to as “simulated physiological oocyte maturation” (SPOM), 
maintains meiotic arrest through combining two methods of cAMP maintenance (Albuz et al., 
2010). Incubation of oocytes for two hours in a pre-maturation medium containing a combination 
of both IBMX and forskolin causes nearly a 67-fold spike in cAMP within the oocyte (from 3 
fmol to 200 fmol), effectively preventing meiotic resumption by mimicking the increase in 
cAMP levels that occur during the pre-ovulatory gonadotropin surge (Albuz et al., 2010). The 
combined effect both increases cAMP production (forskolin) and prevents cAMP degradation 
(IBMX), to maintain maximal cAMP levels. Once removed from this pre-maturation medium, 
oocytes in the SPOM protocol are cultured in an extended maturation of 30 hours, where the 
IVM medium is supplemented with another cAMP modulator (cilostamide, allowing only 
gradual cAMP degradation) with the aim of meiotic resumption being restricted to a decreased 
rate.  The SPOM system has increased bovine embryo production rates compared to IVM (26% 
and 8% respectively) as well as implantation rates (53% cf 28%).  
One of the major problems associated with the use of meiosis promoting factor (MPF) 
inhibitors, is that they have been shown to cause changes in the oocyte ultra-structure. By 
interrupting cumulus cell-oocyte communication, and causing organelle disruptions the effects of 
MPF inhibitors may be long-lasting and debilitating for oocyte competence towards embryo 
development (Fair et al., 2002; Lonergan et al., 2003). To date, however, those factors that work 
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by directly maintaining cAMP levels, cAMP modulators, appear to be the best candidate for 
delaying meiotic maturation, potentially causing fewer aberrations than do other methods of 
MPF inhibition (Bilodeau-Goeseels, 2003a, b).  
This project compared oocytes that were matured using a conventional 24-hour 
maturation, and those using a modified SPOM method, with a 2-hour pre-incubation and a 24-
hour maturation period to determine the effects of cycloheximide and IBMX on select oocyte 
cytoplasmic maturation indicators.  The hypotheses were that; 1) holding oocytes in cAMP 
modulators would reversibly maintain both meiotic arrest and gap junction communication and 
that cytoplasmic maturation would proceed during this period. 2) Oocytes undergoing extending 
IVM, including both pre-maturation and IVM, would have more complete cytoplasmic 
maturation than those oocytes undergoing conventional IVM. The aim was to determine if the 2-
hour pre-incubation period was, in fact, adequate at maintaining gap junction-mediated 
communication between cumulus cells and oocytes for a long enough period to improve 
cytoplasmic maturation, and thus oocyte competence.  
3.2 Methods 
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich Chemical Co. 
(St. Louis, MO, USA). 
3.2.1 Animals 
All procedures in this experiment were approved by the Louisiana State University 
Agricultural Center’s Institutional Animal Care and Use Committee and were carried out at the 
LSU Reproductive Biology Center, St. Gabriel, LA, USA. Thirty-five mixed breed beef cows, 
housed on pasture with ad libitum access to mixed native grasses supplemented with hay and full 
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access water were used for intermittent oocyte collection throughout autumn 2014 and spring 
2015.  
3.2.2 Experimental Design 
The effect of in vitro maturation system on completion of oocyte cytoplasmic maturation 
was assessed through comparison of immature oocytes to oocytes at different stages of in vitro 
maturation. Oocytes were recovered via transrectal ultrasound-guided oocyte aspiration on 12 
days, and were randomly assigned by day to one of four treatment groups (Table 3.1). 
Table 3.1 Treatment groups for analysis of the effect of in vitro maturation protocols on 
completion of oocyte cytoplasmic maturation  
3.2.3 Oocyte Retrieval 
Oocytes were recovered, as cumulus-oocyte complexes (COCs), from live cattle using 
ovum pick-up (OPU, Figure 3.1). Methods were adapted from those used by Bailey (Bailey, 
2014). For oocyte recovery, cows were restrained in a manual squeeze chute and were 
administered 30 mg xylazine (XylamedTm, VetOne®, Boise, ID, USA) intramuscularly, as a mild 
general sedative. They were then given a 5mL, 2% lidocaine (VetOne®, Boise, ID, USA) 
epidural as a local anesthetic. Ovaries were palpated rectally and held against the vaginal wall so 
follicles could be visualized on ultrasound. The ultrasound probe, an 8.5MHz convex transducer, 
within a hard plastic needle guide (Boland Vet Sales, Keller, TX, USA), and connected to a 
SonoSite® MicroMaxx® ultrasound, was inserted through the vaginal canal and held against the 
vaginal wall against the ovary. Once follicles were visualized all follicles greater than 3 mm in 
Control Pre-Maturation
Immature (GV) 1; Immediate Fixation (n=285) 2; Pre-maturation (n=280)
Mature (MII) 3; Conventional IVM (n=300) 4; Extended IVM (n=290)
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diameter were aspirated, using an 18-guage, three inch long disposable needle (AirTite Products 
N183) connected to the ultrasound through the needle guide system. Aspiration was performed 
using negative pressure, achieved by connecting a vacuum pump (Cook Veterinary Products, 
Australia). The needle was connected to an embryo collection filter (Agtech Inc., Manhattan, KS, 
USA) which was first primed with collection medium (Appendix). Aspiration system was rinsed 
with collection medium after each ovary to prevent oocytes from being held in the aspiration 
lines. The needle was replaced, and ultrasound probe cleaned after each cow. Once recovered, 
oocytes were placed in Hepes-TALP (Appendix) at 38.5°C until further processing. 
Figure 3.1. Drawing by E. Meintjes depicting the transvaginal ultrasound-guided follicular 
aspiration procedure (Godke et al., 2014). 
3.2.4 Pre-Maturation 
Oocytes in treatment groups 2 and 4 were incubated  for two hours in a  pre-maturation 
medium, at 38°C in a non-CO2 incubator prior to further processing.  This medium was based on 
Hepes-TALP, supplemented with 0.1µM Forskolin and 0.5µM IBMX (3-Isobutyl-1-




monitor and follicles are located.  An 18-gauge disposable collection needle, located inside the 
ultrasound probe, is connected to a suction pump via polyethylene tubing.  The collection 
needle is inserted through the vagina  wall i to ach follicle, and the follicular fluid along with the 
oocyte is aspirated out of the ovary. The needle is changed after each cow, tubing and needles 
are rinsed with collection medium (D-PBS with 0.1% heparin and 1% BCS), and the follicular 
fluid and oocytes are deposited into an embryo collection filter (Agtech Inc., Manhattan, KS, 
USA).  All media used during collection is maintained at 39°C. 
 
 
Figure 3.1. Diagram of transvaginal ultrasound-guided follicular aspiration. (Drawing by 




Oocytes in treatment 1 were washed four times through standard IVM medium, and 
were divided evenly into four groups for the 8, 13, 18, and 23-hour time samples. Individual four-
well plates were previously prepared and labelled for each of these time samples, and 
contained nine to twelve oocytes in each 35 µL drop. Oocytes were cultured in 5% CO2 at 39°C 
for the required times, ranging from 8 to 23 hours.  
 Oocytes in treatment 2 (extended IVM) were washed four times through the pre-IVM 
medium with FSK and IBMX, and then left in this medium for two hours in a non-CO2 incubator 
and washed three times in Hepes-TALP before being moved to either IVM medium (Treatment 
4) or proceeding with the staining protocol (Treatment 2).  
3.2.5 Oocyte Culture 
Oocytes in treatments 3 and 4 were put through a standard in vitro maturation (IVM) 
protocol. Those oocytes in treatment 3 were placed immediately into IVM following retrieval, 
while those in treatment 4 had a 2-hour pre-maturation incubation described above prior to IVM. 
Oocytes were washed 3 times in IVM medium (Appendix) before being split into cohorts 
of 8-12 and placed into 35µL drops of IVM medium under oil. IVM dishes were then placed in a 
humidified incubator at 38.5°C under 5% CO2 for 22 hours.  
3.2.6 Staining and Fixation 
Oocytes in each treatment group (one through four) were split into two different analysis 
methods, such that half of the oocytes for each treatment were analyzed by each method. 
In analysis method A, oocytes were stained with Calcein AM to identify gap junction 
closure between the oocyte and the surrounding cumulus cells. Cumulus-oocyte complexes were 
incubated in 0.1µg/mL Calcien AM (Life Technologies, Eugene OR) for 15 minutes. Following 
this oocytes were vortexed for two minutes in 1mg/mL hyaluronidase in Hepes-TALP to remove 
cumulus cells. Denuded oocytes were then incubated for 30 minutes at 38°C in 1µg/mL Hoechst 
33342 (Life Technologies) for nuclear identification. The stained oocytes were mounted on slides 
under 10µL of vectashield antifade mounting medium (Vector Laboratories,  Burlingame, CA, 
USA). Slides were viewed on a wide field fluorescent microscope at 400X magnification and 
images were saved for each oocyte (Figure 3.2). 
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Figure 3.2. Calcein AM staining of oocytes. A. Six oocytes stained after a two-hour pre-
incubation period in IBMX and forskolin. B. Eight oocytes stained after extended in vitro 
maturation, including a two-hour preincubation and 24-hour maturation. In both A and B, arrows 
indicate gap junction functional status as below; 1- open, 2- partially open, 3- closed.  
Oocytes assigned to analysis method B were denuded using the above mentioned 
protocols prior to staining. They were then incubated for 40 minutes in 400nM MitoTracker deep 
red (Life Technologies, M22426), diluted in Hepes-TALP at 38°C in a non-CO2 environment 
(Figure 3.3). MitoTracker stained oocytes were rinsed and fixed in 4% paraformaldehyde for one 
hour at room temperature. They were then placed in an 0.5% Triton X-100 blocking solution for 
30 minutes at room temperature before being incubated for 30 minutes at 38.5°C with 1µg/mL 
Alexa Flour 488 conjugated Phalloidin (Life Technologies) stain, for identification of F actin 
(Figure 3.4). Finally, oocytes were washed for 10 minutes and stained with 1µg/mL Hoechst 
33342 for 30 minutes before rinsing and mounting on slides under 10µL of Vectashield anti-fade 
mounting medium.  Oocyte staining was analyzed on a wide field fluorescent microscope (Nikon 
H600L equipped with a Zyla SCMOS camera) at 600X magnification and images were saved for 









Figure 3.3. Mitotracker Deep red staining of oocyte mitochondria. A. An oocyte displaying 
peripheral mitochondria. B. An oocyte with mitochondria found in diffuse clusters throughout 
ooplasm. C. An oocyte with mitochondria evenly diffuse throughout ooplasm.  
Figure 3.4. Phalloidin staining of oocyte F-actin, representing tubulin aggregation. A. An oocyte 
with diffuse, unpolymerized F-actin. B. An oocyte with disaggregated F-actin forming short 
polymers. C. An oocyte displaying fully networked, densely aggregated F-actin.  
Images from both analysis methods were later analyzed by an observer blinded to 
treatment, and numerically coded for stain parameters (Table 3.2) that corresponded to 
previously documented indications of oocyte maturity (Thomas et al., 2004b, b; Adona et al., 




Table 3.2 Criteria for classification of oocyte maturation status for each parameter analyzed. 
3.2.7 Statistics 
All statistical tests were performed in RStudio (Team, 2016). Results for analysis method 
A were compared using chi square analysis to determine if there were any differences in the 
proportion of oocytes at each level of gap junction communication between treatments and 
meiotic maturation. Results for analysis method B were assessed to determine significant 
interactions between treatment, meiotic maturation, mitochondrial location and F-actin 
aggregation, using chi square analysis of the proportion of oocytes representing each 
characteristic. Specific differences were determined using the Kruskal-Wallis Nemenyi post-hoc 
test. Significance was set at P<0.05. 
3.3 Results 
The majority of oocytes that were fixed immediately following retrieval were found in 
the germinal vesicle (GV) stage of meiotic arrest, and this was not changed over the course of the 
2 hour pre-incubation period (P=0.62). Oocytes in both groups that underwent in vitro maturation 
(IVM) progressed through meiosis, with oocytes that underwent conventional meiosis having a 
slightly higher proportion of oocytes completing meiosis than those that were held in pre-
incubation prior to IVM (63% and 54% of oocytes reaching metaphase II, respectively). Results 
outlined in Table 3.3 show that treatment had an overall significant effect on meiotic stage 
Assigned Score Meiotic Status Gap Junctions Mitochondria F-Actin
Immature 1 Germinal vesicle Open Peripheral Disaggregated
Maturing 2 Metaphase I Partially open Diffuse Partially aggregated
Mature 3 Metaphase II Closed Diffuse clusters Polymerized network
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(P<0.001). Both methods of maturation showed significantly different maturation profiles than 
did immature fixed oocytes or oocytes exposed to a pre-maturation period only (P< 2e-16 for all 
comparisons). It is important to note that there was a significant difference in maturation profiles 
between conventional and extended IVM groups as well (P=0.0042) with conventional IVM 
having a slightly improved maturation rate.  
Table 3.3. Proportion table depicting the meiotic status of oocytes in each treatment group and 
the overall average meiotic phase within each treatment.  
Superscripts(A,B,C) indicate significant differences in the overall distribution of oocyte meiotic 
status between treatments at p<0.005. 
Gap junctions were found to be open in the majority of immature fixed oocytes. This 
function was maintained, though not entirely throughout the pre-maturation incubation 
(P=0.0036) with a 13% increase in the number of oocytes with closed gap junctions occurring 
following the pre-incubation (Table 3.4). Following extended IVM, gap junctions continued to 
close showing a lower proportion with open gap junctions than immediately following pre-
maturation (34% and 40% open, respectively), but without a significant change to the overall 
average profile (P=0.79 and P=0.0021 for comparison to pre-incubation and immature, 
respectively). When compared to all other treatment groups, oocytes cultured in a conventional 










GV 0.77 (219) 0.79 (221) 0.11 (33) 0.12 (35) 0.44 (508)
MI 0.11 (31) 0.08 (22) 0.15 (45) 0.2 (58) 0.14 (162)
MII 0.05 (14) 0.02 (6) 0.63 (189) 0.54 (157) 0.32 (370)
Unknown/ Degenerate 0.05 (14) 0.11 (31) 0.11 (33) 0.14 (41) 0.1 (115)
Most Frequently Occurring 
Meiotic Stage
GVA GVA MIB MIIC
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IVM treatment were the most likely to have completely closed gap junctions (43%), which was 
significantly different from all other treatments (P=2.6e-9, P=0.0038, and P=0.0066 for immediate 
fixation, pre-maturation and extended IVM, respectively). As well as treatment having a 
significant overall effect (P<0.001) on gap junction functional status, meiotic phase (P=1.43e-13) 
and the interaction between treatment and meiotic phase (P=7.68e-6) were also significantly 
correlated to gap junction closure, with mature, MII, oocytes being the most likely to have closed 
gap junctions.   
Table 3.4. Proportion table depicting the functional status of gap junctions of oocytes in each 
treatment group and the overall average gap junction function level within each treatment. 
Superscripts(A,B,C) indicate significant differences in the overall distribution of oocyte gap 
junction functional status between treatments at p<0.01. 
All three distinct patterns in mitochondrial distribution were found within each treatment 
group, and while treatment did have an overall effect on mitochondrial location within the 
ooplasm (P<0.001), pairwise post-hoc comparisons found no significant differences between the 
proportion tables of any two specific treatments (P>0.1). The most frequently observed 
orientation for all treatments groups was for mitochondria to be found in clusters throughout the 
entire ooplasm, however oocytes subjected to pre-maturation alone showed the highest 








Open 0.59 (77) 0.4 (50) 0.2 (26) 0.34 (44) 0.38 (196)
Partially Open 0.22 (28) 0.32 (40) 0.37 (48) 0.4 (57) 0.32 (165)




OpenA OpenB ClosedC PartialB
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33-43%, Table 3.5). As with gap junction closure, the interaction between treatment and meiotic 
completion had a significant impact (P=0.0072) on mitochondrial translocation, although nuclear 
status alone was an insignificant factor (P=0.45). Treatment with conventional IVM did result in 
oocytes with the lowest incidence of both peripheral mitochondria and limited mitochondrial 
numbers, indicating that this treatment had the greatest effect on supporting mitochondrial 
maturation.  
Table 3.5. Proportion table depicting the mitochondrial location patterns found in oocytes in 
each treatment group and the overall average mitochondrial location within each treatment. 
Superscripts(A) indicate significant differences in the overall distribution of oocyte mitochondrial 
location between treatments at p<0.05. There was no significant difference found between 
treatment groups. 
Tubulin patterns, as represented by F-actin staining, primarily changed in aggregation 
rather than distribution patterns. Regardless of treatment, few oocytes had tubulin in its 
aggregated form of long filamentous networks, but this was most frequently seen following 
extended IVM (23% cf 9-13%, Table 3.6). Treatment did have a significant effect on the changes 
in tubulin (P<0.01), but the only treatment that showed a significant difference in patterns was 
extended IVM. Oocytes in extended IVM had similar tubulin characteristics to those that were 
fixed immediately in the GV stage (P=0.23) but different characteristics from either oocytes that 







Peripheral 0.07 (11) 0.12 (19) 0.05 (9) 0.17 (27) 0.11 (70)
Diffuse 0.23 (36) 0.15 (23) 0.42 (71) 0.23 (37) 0.26 (166)
Diffuse Clusters 0.37 (57) 0.48 (74) 0.43 (73) 0.33 (53) 0.41 (262)













had been pre-incubated only (P=0.0047), or cultured in conventional IVM without pre-
incubation (P=0.010). 
Table 3.6. Proportion table depicting the tubulin aggregation patterns in oocytes in each 
treatment group and the overall average tubulin patterns within each treatment. 
Superscripts(A,B) indicate significant differences in the overall distribution of oocyte tubulin 
aggregation patterns between treatments at p<0.005. 
3.4 Discussion 
Since so much of oocyte competence is determined by successful, and concurrent, 
meiotic and cytoplasmic maturation, and since in vitro maturation results in maturation occurring 
in an environment quite different from that naturally occurring within the follicle, it is not 
unexpected that the in vitro maturation system is considered to be one of the most critical factors 
in determining the competence of IVM oocytes (Kafi et al., 2005).  Although the effect of low 
concentrations of cAMP is transient in bovines and has been shown to improve overall meiotic 
maturation rates and resultant blastocyst rates by as much as 30% over traditional IVM alone 
(Thomas et al., 2004b), including a high concentration either before or during IVM could 










Disaggregated 0.35 (54) 0.49 (76) 0.51 (87) 0.31 (48) 0.43 (275)
Partially 
Aggregated
0.44 (68) 0.35 (54) 0.34 (58) 0.43 (69) 0.38 (243)
Filamentous 
Network
0.09 (14) 0.11 (17) 0.13 (22) 0.23 (37) 0.14 (90)






DisaggregatedB DisaggregatedB Partially 
AggregatedA
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A previous study in our lab found that this pre-maturation protocol delayed meiotic 
maturation with 85% of oocytes having already resumed meiosis at the start of conventional 
IVM, and only 25% when cAMP modulators were present (Farmer, 2014). However, this meiotic 
inhibition was found to be largely irreversible, with 80.6% of oocytes reaching MII by 
completion of conventional IVM, and only 43.8% of oocytes in extended IVM completing 
meiotic maturation (Farmer, 2014), with similar results seen in other studies (Gharibi et al., 
2013). Results in this study were in agreement with these previous studies, in that meiotic 
maturation rates were decreased after exposure to IBMX and Forskolin. These results 
corroborate the belief that cAMP modulation may be less reversible  in the bovine than was 
originally believed. However, meiotic maturation rates were universally lower than anticipated in 
this study, indicating that there may have been unrecognized confounding effects decreasing the 
oocyte competence.  
The goal of exposing oocytes to cAMP modulators is that by blocking the MPF pathway, 
gap junctions between oocytes and cumulus cells will be maintained (Thomas et al., 2004b). This 
will allow continued communication, while holding oocytes in meiotic stasis, which should 
encourage oocyte cytoplasmic changes necessary for early embryonic development to occur 
(Thomas et al., 2004b). However, results of the current study indicated that incubation in IBMX 
and forskolin was only partially successful at maintaining gap junctional communication and that 
this was largely irreversible. There was a significant decrease in the proportion of oocytes with 
open gap junctions between post-collection and following the pre-maturation incubation, but no 
notable difference in gap junction function between incubation and following IVM after the pre-
incubation protocol. This was significantly different from the results seen for oocytes that were 
 !38
matured in vitro without a pre-incubation, which experienced a more extensive cessation of gap 
junctional communication. These results suggest that cAMP modulators, specifically IBMX and 
forskolin, may be less effective than intended for improving oocyte competence. These results 
are in corroboration with those published by Razza et al, wherein oocytes cultured in  extended 
IVM were found to exhibit ultrastructural characteristics more similar to immature oocytes than 
to conventionally in vitro matured oocytes (Razza et al., 2015). Oocytes exposed to IBMX and 
forskolin had decreased smooth endoplasmic reticulum, mitochondrial and lipid volume than 
IVM oocytes, but increased vesicle volume (Razza et al., 2015). 
The major problem with gap junctions closing is that molecules and factors from cumulus 
cells that are necessary for oocyte cytoplasmic maturation are blocked from entry into the oocyte 
(Thomas et al., 2004b). The two cytoplasmic factors analyzed in this study, mitochondrial 
relocation and F-actin polymerization, both  showed insignificant improvements in measurable 
maturation following the pre-incubation protocol.  
One unexpected result of this study is that a high degree of vacuolization was viewed 
within the oocytes, recognizable as well defined roughly circular areas within the cytoplasm that 
were unstained with either Mitotracker to Phalloidin (Figure 3.4). While vacuoles were present in 
large numbers in oocytes of all treatment groups, they appeared to be far more common in 
matured oocytes, both those with and without the pre-incubation prior to maturation. High levels 
of vacuoles have previously been associated with oocytes of decreased developmental 
competence (Coticchio et al., 2016; Nottola et al., 2016). The fact that these are developing over 
the course of maturation, and not present in high numbers in immature oocytes, may be further 
indicative of sub-optimal maturation conditions resulting in declining oocyte competence. 
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Further, it is possible that the development of this high degree of vacuolization may be 
interfering with proper migration of organelles, disrupting measurement of these cytoplasmic 
maturation parameters.  
Figure 3.5. Image of an oocyte stained with phalloidin, showing a high degree of vacuolization 
visible as dark unstained circles within ooplasm. 
Overall, results indicate that a two-hour incubation in forskolin and IBMX is likely to be 
insufficient for increasing in vitro embryo yield. Although gap junctions are maintained and 
meiotic stasis is achieved in some oocytes, both results are only achieved in a small proportion of 
oocytes, and both are seen to be largely irreversible, preventing proper resumption of meiosis 
and development following removal of cAMP modulators. Further, the inability of modulators to 
maintain full gap junction communication results in irregular results at permitting cytoplasmic 
maturation as indicated by the fact that neither mitochondrial migration nor tubulin aggregation 
was significantly improved by the pre-maturation protocol. Finally, the formation of vacuoles 
during both IVM protocols is further proof that current in vitro culture conditions are suboptimal 
and must be improved upon before we will see increased embryo production rates.  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CHAPTER IV 
THE EFFECT OF FOLLICULAR WAVE PHASE AT TIME OF OPU ON 
BOVINE OOCYTE CYTOPLASMIC MATURATION AND 
DEVELOPMENTAL COMPETENCE 
4.1 Introduction 
Success of any in vitro embryo production program requires first that oocytes collected 
be not only numerous, but of optimal developmental competence (Seneda et al., 2001).  The 
follicular environment may play a key role in regulating oocyte growth and development. As 
such, oocytes recovered from larger follicles, which have had more time to grow and receive 
developmental signals from follicular fluid and granulosa cells, are considered to be more 
competent, producing 5-10% more embryos, than those recovered from small growing follicles 
(Fair et al., 1995; Hagemann et al., 1999; Hagemann, 1999). As the follicle continues to grow 
and becomes dominant, it produces estradiol and inhibin, both of which exert negative feedback 
activity on follicle stimulating hormone (FSH), causing apoptosis and regression of subordinate 
follicles (Ireland et al., 1984; Kaneko et al., 1997; Ginther et al., 2000; Bleach et al., 2001). The 
follicular wave is commonly divided into three distinct phases; at the start of the wave all 
follicles are growing together (follicle growth), but by mid-wave (peak) a single dominant 
follicle has emerged which deviates and grows to pre-ovulatory sizes while inhibiting further 
development of subordinate follicles (Sunderland et al., 1994). The third phase, referred to as the 
atretic phase, is dominated by regression of all subordinate follicles. These effects combine to 
have the result that both the total number, and average developmental competence of oocytes 
recovered can vary greatly based on follicle wave phase at the time of collection (Seneda et al., 
2001).  
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Despite the benefits of waiting to collect oocytes from large pre-ovulatory follicles, 
previous studies have found that oocytes collected during the follicle growth phase had a higher 
degree of competence than those collected during the dominance phase (Hagemann et al., 1999; 
Seneda et al., 2001; Machatkova et al., 2004). In fact, the presence of a dominant follicle has 
been found to not only decrease the competence of oocytes recovered from subordinate follicles 
but also from the oocytes within the dominant follicles themselves (Hagemann, 1999). Oocytes 
collected during the regression phase were not necessarily of depressed competence, and even a 
high degree of follicle atresia had no negative impact on oocyte competence (Hagemann et al., 
1999). However, oocytes collected during the growth phase of follicular waves, when there is no 
atresia present, have been shown to be of an overall greater competence, as well as improved 
recovery rates (Seneda et al., 2001; Machatkova et al., 2004). 
Despite this understanding, most commercial oocyte collection programs rely on 
performing follicular aspirations on random days of the cows’ estrous cycles, rather than 
employing a system to time oocyte recovery (Morotti et al., 2014; Cavalieri et al., 2017). In 
practices that do try to perform timed oocyte pick-up (OPU), there is disagreement on whether or 
not follicular atresia has negative effects on oocyte competence. As such, there is a lack of 
consensus on when OPU is best performed for maximal oocyte competence and quantity. This 
project was designed with the objective of determining the role of follicular wave phase and 
ovarian dynamics on oocyte collection rates, and oocyte cytoplasmic competence. The 
hypotheses were that; 1) Oocyte recovery rates would be lowest at wave peak but that oocyte 
competence would be lowest during follicle atresia. 2) Oocytes recovered during wave peak 
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would be of greater developmental competence than those collected from either growing or 
atretic follicles.  
4.2 Methods 
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich Chemical Co. 
(St. Louis, MO, USA). 
4.2.1 Animals 
All procedures in this experiment were approved by the Louisiana State University 
Agricultural Center’s Institutional Animal Care and Use Committee and were carried out at the 
LSU Reproductive Biology Center, St. Gabriel, LA, USA. Thirty-six mixed breed beef cows, 
housed on pasture with ad libitum access to mixed native grasses supplemented with hay and full 
access water were used for oocyte collections from June 2016 through March 2017. 
4.2.2 Experimental Design 
This project was designed as a repeated measures, treatment cross-over design. Oocytes 
were collected from live cattle, at 3 different points within the follicular wave to represent the 
cohort of oocytes available during follicle growth (day-4 of a new wave), peak (day-8), and 
atresia (day-12). Each cow was used on three sequential cycles, so that collections would occur 
during each wave phase for every cow. The entire project was repeated twice with different 
groups of cows.  
Stimulation of a new follicular wave was achieved through performing a dominant 
follicle removal (DFR) on all cows. During the DFR, follicles greater than 6 mm in diameter 
were aspirated using the same transvaginal ultrasound-guided follicle aspiration (TUGA) 
techniques as for oocyte collection. Cows were then randomly assigned to one of three groups, to 
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determine oocyte collection day, though all cows were housed on the same pasture. Using a 
cross-over design, this DFR followed by oocyte retrieval was repeated three times so that each 
cow was collected during each follicular phase.  
4.2.3 Oocyte Retrieval 
Cumulus-oocyte complexes (COCs), from live cattle using transrectal ultrasound-guided 
oocyte aspiration, using methods described above in section 3. Cows were restrained in a manual 
squeeze chute, administered 30 mg xylazine and given a 5mL, 2% lidocaine epidural. Ovaries 
were palpated rectally and held against the vaginal wall so follicles could be visualized on 
ultrasound and aspirated using an ultrasound probe that had been inserted vaginally. Once 
follicles were visualized all follicles greater than three mm in diameter were aspirated. Follicular 
fluid was aspirated directly into a 50mL FalconTM tube that had been primed with collection 
medium. Tubes were labelled with each cow’s identification number and a new collection tube 
was used for each cow.  The aspiration system was rinsed with collection medium after each 
ovary to prevent oocytes from being held in the aspiration lines.  
During the oocyte retrieval process, parameters for each ovary were recorded including; 
the number of follicles aspirated and the average size of follicle present, whether or not a 
dominant follicle was present and its size if noted, and whether or not a corpus luteum was 
present. Once recovered, oocytes were placed in Hepes-TALP at 38.5°C until further processing. 
The total number of oocytes recovered per cow was recorded as well as their visible grade, based 
on cumulus cell enclosure and cytoplasm appearance. All oocytes for each treatment from a 
single day were pooled at the end of the recovery process for all allotted cows, and were then 
randomly divided into level two treatment groups. 
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4.2.4 Oocyte Maturation 
One-third of the recovered oocytes were fixed immediately following retrieval to 
represent germinal vesicle stage oocytes for the staining analyses. The remaining two-thirds of 
the recovered oocytes were put through a standard in vitro maturation (IVM) protocol following 
retrieval. Oocytes were washed 3 times in TCM-199 based IVM medium (Appendix) before 
being split into cohorts of 8-12 and placed into 35µL drops of IVM medium under oil. IVM 
dishes were then placed in a humidified incubator at 38.5°C under 5% CO2 for 22 hours. 
Following maturation, half of the matured oocytes were fixed and stained using the same 
protocols as for the immature oocytes. The remaining oocytes were subjected to parthenogenetic 
activation and were cultured to determine embryo production rates.  
4.2.5 Parthenogenetic Activation and Embryo Culture 
Following completion of maturation, cumulus-oocyte complexes were rinsed in Hepes-
TALP before being denuded by vortexing for two minutes in 1mg/mL hyaluronidase. Denuded 
oocytes were recovered from hyaluronidase, rinsed three more times in Hepes-TALP and stained 
in 5µM Fluo 3-AM (Molecular Probes, F1242), to identify free cytoplasmic calcium. Oocytes 
were incubated in 20µL droplets of Fluo 3-AM under oil for 45 minutes at 38.5°C before being 
washed in Hepes-TALP again. Pre-activation images were taken on an inverted microscope 
(Nikon Eclipse TE200 equipped with a Hitachi camera) at 400X magnification. 
Oocytes were then chemically activated in a 20µL droplet of 20µM ionomycin for five 
minutes. They were washed again in Hepes-TALP and post-activation images were taken, and 
staining intensity recorded. Oocytes were cultured for four hours in 30µL drops of 200mM 
DMAP under oil and at 38.5°C, to complete activation. Activated parthenotes, were rinsed in 
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synthetic oviductal fluid (SOF) medium (Appendix) before being transferred to fresh 35µL drops 
of SOF under oil. Presumptive embryo were cultured at 38.5°C, in a 5% CO2 humidified 
incubator for 7 days. Embryo cleavage was recorded on day-2 of culture, development to the 8-
cell stage was recorded on day-4.  
Fluo 3-AM images were coded on a 0 to 4 scale based on staining intensity, with 0 
indicating no fluorescence visible, and 4 representing high intensity fluorescence throughout the 
entire cytoplasm. Fluorescence was compared between oocytes pre- and post-ionomycin 
activation, and average fluorescence levels at both time points were compared across the 
different treatment groups (follicular phases at time of oocyte recovery). Oocytes were separated 
into different culture drops based on their post-activation staining intensity, so effect of 
cytoplasmic calcium levels on embryo development rates could be tracked. 
Figure 4.1. Staining reference for Fluo3-AM levels. Image 1 on the left represents an oocyte 
graded “1” or “slight” and image 2 on the left represents an oocyte graded “3” or “high” 
fluorescence.  
4.2.6 Staining and Fixation 
Both immature and mature oocytes, with the exception of those that were 
parthenogenetically activated for embryo production, underwent the same fixation and staining 




immediately following collection (germinal vesicle stage) or following 22-hours of IVM (MII 
stage), by vortexing in 200mL of 1mg/mL hyaluronidase in a 1.5mL microcentrifuge tube for 2 
minutes. Denuded oocytes were stained with 400nM Mitotracker deep red (Molecular Probes, 
M22426) for 30 minutes at 38.5°C before fixation in 2% paraformaldehyde. Inositol 1,4,5-
trisphosphate receptor 1 (IP3R1) identification was performed using a permeabilization protocol 
followed by a one hour incubation at 38.5°C in a primary antibody against IP3R1 (1:500, Abcam, 
5804). Oocytes were then washed followed by incubation in a secondary goat antibody against 
rabbit IgG and conjugated with Alexa Fluor 488 (1:500, Abcam, 150077). Finally oocytes were 
mounted on slides under 10µL of Vectashield containing DAPI. Oocytes were viewed on a wide-
field Nikon microscope at 600X, and images were deconvolved 10 times before being analyzed 
by a blinded observer for staining characteristics.  
Using similar guidelines to those outlined in section 3, oocytes were coded for meiotic 
maturation based on DAPI staining of the chromatin (germinal vesicle, metaphase I or metaphase 
II) and for mitochondrial maturation as determined by Mitotracker identification of 
mitochondrial location within the ooplasm (peripheral, clustered, diffuse). Inositol 1,4,5-
trisphosphate receptor 1 expression was measured as total cell fluorescence in Image J, corrected 
by subtracting individual image background fluorescence intensity.  
4.2.7 Statistics 
All statistical tests were performed in RStudio (Team, 2016). Results involving embryo 
development rates were compared using chi square tests to determine if there were any 
interactions between follicular phase, cytoplasmic calcium, and embryo development. Results of 
oocyte staining were assessed to determine significant interactions between follicular wave 
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phase, meiotic maturation, mitochondrial location and IP3R1 expression, using linear models 
with a step-function analysis of variance (ANOVA) to determine the best model. Chi square 
analysis was performed comparing the proportion of oocytes at each mitochondrial maturation 
level against follicular wave phase. Pairwise interactions were analyzed using the Kruskal-Wallis 
Nemenyi post-hoc test. Included into the step-wise ANOVA model, were factors recorded during 
OPU to determine if follicular phase had an effect on apparent oocyte grade or oocyte collection 
rates. 
Figure 4.2. A. In immature oocyte stained to identify chromatin (blue) and IP3R1 (green). B. A 
metaphase II oocyte after 24 hours of IVM stained to identify chromatin (blue) and IP3R1 
(green). C. An oocyte stained with Mitotracker deep red to identify chromatin, found in the 
diffuse orientation here. 
4.3 Results 
A total of 1,054 oocytes were collected over the course of this trial (364, 374, and 316 on 
day-4, day-8 and day-12 respectively). Of these 812 were used for analysis (Table 4.1), with the 
remainder being either lost during handling or discarded for visible degeneration.  
Table 4.1. Number of oocytes collected and allocated to each analysis method 
Collection Day Germinal Vesicle Metaphase II Embryo Production
Follicle Growth n=63 n=76 n=107
Follicle Peak n=86 n=101 n=117
Follicle Atresia n=96 n=74 n=92
 !48
CBA
With the exception of a positive correlation between number of follicles aspirated and 
oocyte recovery (recovery rate=61%, P=2e-16, r2=0.75), none of the recorded variables had an 
effect on the number of oocytes that were recovered (Table 4.2). Follicular phase did not affect 
either the number of follicles present or the number of oocytes recovered, and there was no 
tendency for oocytes from larger follicles to be higher grade at the time of recovery (P=0.23, 
r2=0.11). Further, follicular wave phase had no bearing on oocyte grade P=0.786). 
Table 4.2. Oocyte collection parameters by follicle phase at time of OPU. 
*There were no significant interactions between follicular phase and any of the parameters 
measured (P>0.05). 
Completion of meiotic maturation was strongly correlated to whether oocytes had been 
subjected to IVM or not (P=0.132e-11, r2=0.68), but was not significantly affected by follicle 
phase (P=0.9). Mitochondrial migration appeared to occur independently of either IVM status or 
meiotic maturation (Table 4.3), but IP3R1 expression significantly increased over the course of 
IVM (P=0.013), and in correlation with meiotic completion (P=0.007, Table 4.4). Overall, the 
most important factor affecting IP3R1 expression levels was the follicular phase at the time of 
OPU (P=0.0056). The highest IP3R1 expression was found in oocytes collected during follicular 
growth (day-4 post-DFR) and the lowest expression levels were found in oocytes recovered from 
atretic follicles (day-12 post-DFR). 
Collection Parameters Follicle Growth Follicle Peak Follicle Atresia
Number of Follicles 
Present (mean per cow)
17.4 18.1 15.4
Number of Oocytes 
Collected (mean per cow)
10.1 10.4 8.8
Proportion of A/B Grade 
Oocytes (mean per cow)
0.53 0.45 0.48




Table 4.3. The effect of follicular phase and IVM on mitochondrial distribution patterns in 
bovine oocytes. 
*Neither maturational status nor follicular phase at the time of OPU had a significant effect on 
mitochondrial location (P>0.05). 
Table 4.4. The effect of follicular phase and IVM on IP3R1 expression levels in bovine oocytes. 
*The interaction between maturation status and follicular phase had an overall significant effect 
on IP3R1 expression (P=0.013). Oocyte maturation alone was not a significant factor in IP3R1 
expression (P=0.13). ABWhen looking only at the effect of follicular phase, there was a 
significant difference in IP3R1 expression between oocytes collected during follicle growth and 
atresia (P=0.013), but not between oocytes from follicle peak and either growth or atresia 
(P=0.179 and P=0.974 respectively).  
Embryo development rates for this project were uniformly low, with cleavage rates of  
19.4%, 17.6% and 12.2% for oocytes collected during follicle growth, peak and atresia 
respectively (P=0.0.14, Table 4.5). Development beyond the 8-cell stage was also low across all 




Follicle Growth Follicle Peak Follicle Atresia
GV (n) MII (n) GV (n) MII (n) GV (n) MII (n)
Peripheral 0.164 (6) 0.169 (9) 0.295 (14) 0.17 (9) 0.215 (13) 0.059 (3)
Diffuse 0.5 (20) 0.677 (37) 0.464 (23) 0.508 (28) 0.545 (34) 0.677 (33)
Clusters 0.064 (2) 0.016 (1) 0.142 (7) 0.152 (8) 0.073 (5) 0.019 (1)
Few 
Mitochondria 0.272 (11) 0.138 (7) 0.099 (5) 0.17 (9) 0.167 (10) 0.245 (12)
IP3R1 Accumulation
Follicle GrowthA Follicle PeakAB Follicle AtresiaB
GV (n) MII (n) GV (n) MII (n) GV (n) MII (n)
Low 0.59 (23) 0.407 (22) 0.551 (27) 0.436 (24) 0.468 (29) 0.633 (31)
Slight 0.282 (11) 0.315 (17) 0.347 (17) 0.436 (24) 0.468 (29) 0.245 (12)
Moderate 0.051 (2) 0.204 (11) 0.082 (4) 0.128 (7) 0.064 (4) 0.122 (6)
High 0.077 (3) 0.074 (4) 0.02 (1) 0 0 0
Total (n) 39 54 49 55 62 49
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(P=0.44), but was slightly better from oocytes collected during wave peak. However, Fluo 3-AM 
fluorescence levels had a significant effect on cleavage rates (P<0.01) and this was maintained 
for embryo development rates (P<0.001). Both cleavage and embryo development rates were 
higher in oocytes with low to no Fluo 3-AM staining at the time of parthenogenetic activation, 
with cleavage rates of 40%, 11%, 20%, and 2% and embryo development rates of 13%, 3%, 2% 
and 0% for nil fluorescence, slight, moderate and high fluorescence levels respectively.  
Table 4.5. Embryo development rates as a function of follicular phase at the time of OPU, and 
oocyte cytoplasmic Fluo 3-AM fluorescence levels at the time of parthenogenetic activation.  
4.4 Discussion 
In addition to factors integral to the oocyte itself,  previous studies have found that oocyte 
competence can be affected by follicle size and estrous cycle stage (Gilchrist et al., 1995). 
Estrous cycle synchronization in cows prior to oocyte retrieval through the use of exogenous 
gonadotropins to control follicle wave emergence, has been reported to have an overall effect of 
improving oocyte quantity and developmental competence, as well as embryo production rates 
when compared to unsynchronized cows (Cavalieri et al., 2017). The study presented here aimed 
to look at oocytes collected from follicles of similarly staged cohorts, at three specified points in 
the follicular wave to analyze the direct effect of the follicular environment prior to OPU, on 
oocyte competence. On initial analysis, we didn’t find that a significant effect of follicular phase 
No Fluorescence Slight Moderate High
2-Cell (n) 8-Cell (n) 2-Cell (n) 8-Cell (n) 2-Cell (n) 8-Cell (n) 2-Cell (n) 8-Cell (n)
Follicle 
Growth 0.2 (3) 0.067 (1) 0.12 (2) 0 0.38 (8) 0 0.06 (1) 0
Follicle Peak 0.6 (26) 0.26 (11) 0.2 (2) 0.1 (1) 0 0 0 0
Follicle 
Atresia 0.4 (12) 0.07 (2) 0 0 0.21 (6) 0.07 (2) 0 0
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on any of the parameters recorded; oocyte number, recovery rate, or initial grade Presence or 
absence of either a corpus luteum or a dominant follicle also failed to significantly affect on 
oocyte collection rates or competence. These results suggest that, all other factors being equal, 
timing OPU for specific estrous stages may be less beneficial for optimizing oocyte collection 
rates and more important for ensuring that follicles are of a homogenous developmental stage. 
One early study found that, contrary to more recent studies, neither follicle size nor ovarian 
activity at the time of oocyte recovery had any effect on maturation rate (Fukui and Sakuma, 
1980). While current studies were in agreement with this, with regard to meiotic maturation, 
results of the current study indicated that the effect of follicle size on cytoplasmic maturation and 
oocyte competence was rather more complicated. This lends evidence to the concept that while 
meiotic maturation occurs early in the maturation process, prior to the completion of oocyte 
cytoplasmic maturation and asynchronously with the attainment of full developmental 
competence.  
Methods were based on the previously reported findings that completion of cytoplasmic 
maturation is absolutely required before oocytes acquire the competence to support early 
embryonic development (Watson, 2007). Of the many different factors involved in cytoplasmic 
maturation, it has not yet been determined if any one is the best indicator of competence, being 
acquired last or most reliably (Sirard et al., 2006b). Three cytoplasmic determinants were used as 
potential indicators of developmental competence. The changes in mitochondrial distribution that 
occur during oocyte maturation are well described (Matchatkova et al., 2012) and the function of 
mitochondria in energy production, make their redistribution to ensure equal mitochondrial 
allocation to each embryonic cell critical in ensuring developmental competence. It was found 
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that follicular phase did not significantly affect mitochondrial distribution patterns, suggesting 
that oocytes from all follicular stages are equally competent, in this regard. However, although 
insignificant, there was an apparent increase in the number of oocytes with mitochondria 
distributed in clusters when they were collected during follicle peak. Of interest, this study also 
failed to find a significant difference in mitochondrial allocation between GV and MII stage 
oocytes, with the majority of oocytes across all collection days, and both maturational stages 
having the mitochondria already spread diffusely throughout the ooplasm, an orientation that is 
more commonly associated with partially mature oocytes (Matchatkova et al., 2012). These 
results suggest that, while oocyte mitochondrial maturation has already begun by the time 
oocytes are recovered, especially when collected from large follicles, IVM conditions are 
inadequate to stimulate the completion of mitochondrial redistribution. This result has been 
corroborated by past studies, although with the finding that GV oocytes with diffusely distributed 
mitochondria were most frequently recovered from larger follicles (Matchatkova et al., 2012). 
Inositol 1,4,5-trisphosphate receptor 1 is recognized as undergoing a marked increase in 
expression as oocytes mature. Since IP3R1 is expressed on the surface of smooth endoplasmic 
reticulum (SER), by measuring the expression of IP3R1, information about the location and 
density of the SER network as well as the presence of IP3R1 themselves can be postulated. IP3R1 
is a receptor within the SER which, when phosphorylated, initiates release of calcium stores from 
the SER (Wakai et al., 2012). This efflux of Ca2+ from the SER results in the increased 
cytoplasmic Ca2+ levels responsible for initiating oocyte activation at the time of fertilization 
(Malcutt et al., 2006; Whitaker, 2006). As a result, without a high level of IP3R1 expression, 
successful fertilization would not be feasible.  Oocytes in this study were found to exhibit a 
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dramatic and reliable increase in IP3R1 expression as maturation proceeded, across all follicular 
phases. However, this increase was the least recognizable in oocytes collected during the atresia 
phase. In fact, there was a significant difference in IP3R1 expression across follicular phases, 
with oocytes from follicle growth having the highest expression and those from atresia exhibiting 
the lowest expression rates. These results indicate that follicle atresia may carry over to have 
negative effects on oocyte IP3R1 expression, resulting in oocytes having irregularly high levels 
in immature oocytes at the time of recovery, and a lack of increased expression to the normal 
levels following completion of IVM. 
Fluo 3-AM binds calcium and is often used as a viability marker for cultured cells. The 
staining intensity is directly and positively correlated to cytoplasmic calcium levels. Embryo 
development rates were found to be significantly, negatively correlated to stain intensity, and as 
such lower cytoplasmic calcium levels was indicative of mature oocytes of greater competence. 
Because both oocyte activation and successful fertilization rely on calcium signaling pathways, it 
is possible, that these low cytoplasmic calcium levels are correlated to higher levels of 
sequestered calcium and resultant stronger signaling potential in oocytes with low Fluo 3-AM 
stain intensity.  Alternately, it is possible that the high cytoplasmic calcium levels indicated by 
high-intensity Fluo 3-AM staining, is a signal of calcium leaking either from the endoplasmic 
reticulum stores, or through the oolemma from the extracellular media. This calcium leakage 
through membranes could be indicative of atresia of the oocytes, which would explain the failed 
embryonic development from oocytes with high cytoplasmic calcium levels. 
One previous study demonstrated that, while oocyte competence varied with estrous 
cycle stage, this was independent of follicle size or atretic status (Hagemann, 1999), while 
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another study reported that early atresia has no effect on embryo production rates but that heavily 
atretic follicles contain oocytes with decreased developmental potential (de Wit et al., 2000). 
This is indicative that systemic hormones may play a role in oocyte competence (Robertson et 
al., 1996; de Wit et al., 2000). As such, it is feasible, that stimulation protocols, by altering the 
systemic hormones, may have a significant impact on oocyte competence and embryo 
production. Results of the current study disagree with previous results on the importance of 
follicular environment in ensuring successful oocyte maturation and instead lend credence to the 
belief that having a cohort of oocytes at the same developmental stage at the initiation of 
maturation may be of the utmost importance in determining success of in vitro embryo 
production. However, both IP3R1 and Fluo 3-AM staining, as well as embryo development rates 
indicated that oocytes collected during follicular growth had significantly improved 
developmental competence over those collected from atretic follicles, and somewhat improved 
competence compared to oocytes collected during wave peak.  
The biggest downfall to performing oocyte retrieval on random days is that, although 
cows with dominant follicles can easily be identified, it is not possible to differentiate between 
growth stage and atretic follicles (Cavalieri et al., 2017). This potentially high proportion of 
atretic follicles aspirated in unstimulated OPU can effectively decrease the overall average 
competence of collected oocytes, decreasing embryo production rates (Machatkova et al., 2004). 
Because dominant follicles have a negative effect on competence of oocyte from subordinate 
follicles, but there is an apparent increase in oocyte competence as follicles grow, it has been 
suggested that the optimal oocyte recovery period is from large follicles just prior to deviation 
(Hagemann, 1999). It is possible that the poor results seen in oocytes collected during wave peak 
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in this study were due to a heterogenous population of oocytes from dominant follicles and early 
atretic follicles.  
Another possibility is a result of the slightly increased proportion of A/B grade oocytes 
collected during wave emergence, compared to other follicular phases. Initial grades are based 
largely on the cumulus cell investiture surrounding the oocytes. As cumulus cells are a major 
factor in regulating the signals from the external environment that reach the oocyte, and for 
supporting oocyte function (Wrenzycki and Stinshoff, 2013), it is possible that a slight difference 
in the number of cumulus cells surrounding an oocyte can have strong effects on resultant 
embryonic development rates. As oocytes grow, the number of mitochondria increase from at 
few as 10 in germ cells, and 200 in oogonium to an increase to 6,000 mitochondria in primary 
oocytes and 100,000 or more by the completion of maturation (Ferreira et al., 2009; Mau et al., 
2014). It is possible that, in correlation with the low grades apparent, the number of oocytes with 
few mitochondria present may be indicative of oocytes being retrieved prior to the completion of 
the growth phase, lacking the cytoplasmic factors necessary to attain cytoplasmic competence.  
However, until these factors can be verified, and a method of reliably collecting large 
numbers of pre-deviation oocytes can be determined, results here would indicate that timed OPU 
performed frequently enough to collect oocytes only during the follicular growth phase (every 4 




THE EFFECTS OF RECOVERY METHODS ON GENE EXPRESSION 
PROFILES IN BOVINE OOCYTES 
5.1 Introduction 
As in vitro embryo production (IVP) becomes increasingly more popular, the demand to 
improve the efficiency of oocyte recovery also increases. It has become mandatory to not only 
maximize the number of oocytes that can be collected but also to ensure that recovered oocytes 
are of optimal developmental competence to ensure high developmental competence. Following 
the success of exogenous hormone stimulation at improving in vivo embryo production rates, 
many different groups have aimed to improve oocyte recovery rates and competence through 
manipulating their recovery protocols to incorporate different intervals between OPU sessions or 
by using exogenous hormones (Gibbons et al., 1994; Goodhand et al., 1999; Chaubal et al., 
2007). Previous studies have found that use of exogenous hormones to stimulate follicle growth 
improves oocyte development and competence (Sirard et al., 2006a; Cavalieri et al., 2017), while 
others have found that super-stimulation had no effect on oocyte retrieval rates or oocyte 
developmental competence (Oliveira et al., 2016). Super-stimulating females prior to collection 
has been shown to increase embryo production rates anywhere from not at all (Oliveira et al., 
2016) to as much as 7.3% as compared to unstimulated collections (Cavalieri et al., 2017). 
Oocytes recovered following stimulation are from a more homogenous cohort of follicles, often 
further along in development than follicles aspirated in conventional OPU. Thus these super-
stimulated oocytes are believed to be more developmentally competent and to result in higher 
embryo production rates (Cavalieri et al., 2017). However, there is also the potential that the high 
doses of exogenous hormones being administered may negatively affect the normal progression 
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of oocyte development by hastening follicle growth rates, thus being detrimental to oocyte 
competence and embryo production (Lee et al., 2006; Zeng et al., 2009; De los Reyes et al., 
2011).  
Meanwhile follicular atresia, such as that seen in ovaries collected post mortem, has been 
shown to be potentially beneficial to oocyte competence, but the mechanism is as of yet 
undetermined (Blondin and Sirard, 1995; Blondin et al., 1997). It is possible that the beneficial 
effect of post-mortem oocyte recovery is simply attributable to the fact that there is more room 
for selection of mid- to large-sized follicles and that a larger proportion of oocytes recovered 
have a high quality cumulus cell investment when compared to oocytes recovered through ovum 
pick-up (OPU) (Souza-Fabjan et al., 2014). 
While many proteins found in oocytes, are stored during oocyte growth, the period of 
final oocyte maturation is a highly active period during which the oocyte is transcribing mRNA 
and producing, modifying and storing proteins, many of which are necessary for embryonic 
development (Dielman et al., 2002). It is these mRNAs and proteins, accumulated primarily 
during oocyte growth, which drive early embryonic development until the embryonic genome is 
activated at the 8-cell stage (Fair et al., 2007; Ferreira et al., 2009). As a result of oocytes 
matured in vitro are often removed from the follicular environment prior to the completion of 
this mRNA accumulation, in vitro and in vivo matured oocytes have been shown to have not only 
differences in the overall transcriptional profiles but primary differences in pathways effecting 
early embryonic development (Mamo et al., 2011). However, despite the known potential for 
oocyte retrieval interfering with normal developmental dynamics, there is little information 
available on the effects of oocyte recovery methods on gene expression.  This study was 
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designed to answer the query on whether super-stimulation or post-mortem oocyte collection 
change the global gene expression of in vitro matured oocytes in comparison to those collected 
following conventional OPU. It was anticipated that comparing differences in gene expression 
dynamics along with embryo production rates, would help to settle the question of if oocyte 
source could impact developmental competence and in vitro survival. It was hypothesized that; 
1) Super-stimulation would cause irregular gene expression patterns, but post-mortem oocyte 
recovery would not affect transcript profiles. 2) Post-mortem effects will be beneficial for oocyte 
developmental competence resulting in increased embryo production rates.  
5.2 Methods 
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich Chemical Co. 
(St. Louis, MO, USA). 
5.2.1 Animals 
All procedures in this experiment were approved by the Louisiana State University 
Agricultural Center’s Institutional Animal Care and Use Committee and were carried out at the 
LSU Reproductive Biology Center, St. Gabriel, LA, USA. Thirty mixed breed beef cows, housed 
on pasture with ad libitum access to mixed native grasses supplemented with hay and full access 
water were used for oocyte collections from May through November of 2017. 
5.2.2 Experimental Design 
Oocytes were collected via three different collection methods in an attempt to determine 
if the oocyte source affects gene expression or the innate developmental competence of the 
oocytes. Because they are the three most commonly employed methods of oocyte retrieval in 
bovine IVP research, oocytes were collected from live cows via ovum pick-up (OPU) either at 
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random time points in the estrous cycle (Group 1; OPU), or following a super-stimulation 
protocol (Group 2; FSH) and oocytes were retrieved post-mortem from abattoir derived ovaries 
(Group 3; PM). Recovered oocytes from all three treatments were then randomly allocated to one 
of three treatment groups, where they were either snap frozen immediately at the germinal 
vesicle (GV) stage, matured in vitro to the metaphase II (MII) stage and then snap frozen, or 
matured and fertilized. Both groups of snap frozen oocytes were subjected to RNA-Seq to allow 
comparison of gene expression of both immature and mature oocytes between groups, as well as 
the change of gene expression over the course of maturation in each group. Fertilized oocytes 
were then cultured to the blastocyst stage as a measure of developmental competence.  
In all there were six treatment groups compared for sequencing. Table 5.1 shows coding 
for each group.  
Table 5.1. Notation for each of the six treatments used in this study.  
5.2.3 Super-stimulation 
Cows assigned to superstimulation were subjected to a dominant follicle removal (DFR) 
where all follicles greater than 6mm in diameter were ablated, using the same methods described 
below for transvaginal ultrasound-guided follicle aspiration (TUGA). This ensured all cows were 
in the follicular growth phase at the start of the stimulation program. Five mL of prostaglandin 
F2α  (Lutalyse® , dinoprost tromethamine, 25mg, Zoetis Inc, Kalamazoo, MI, USA ) was 
administered intramuscularly (im) to lyse any corpora lutea present, and an intravaginal 
Collection Method Germinal Vesicle Metaphase II
Oocyte Pick-up (OPU) IO MO
Super-stimulation (FSH) IS MS
Post-mortem (PM) IP MP
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progesterone releasing device was inserted (Eazi-BreedTM CIDR® , Zoetis Laboratories, 
Kalamazoo, MI, USA). Cows were administered follicle stimulating hormone (FSH, 
Folltropin® -V, Bioniche Animal Health, Athens, GA, USA) im every twelve hours for a total of 
six doses, beginning 36 hours after DFR. A constant dose schedule was used with injections of 
1.7 mL each to a total of 200mg FSH per cow (20mg/mL). Twenty-four hours after the last FSH 
injection CIDRs were removed, and oocyte retrieval was performed 24 hours after CIDR 
removal, allowing a 48-hour coasting period between the last FSH injection and oocyte recovery 
(Figure 5.1).  
Figure 5.1. Schedule used for the super-stimulation protocol.  
5.2.4 Oocyte Retrieval 
Oocytes collected from both FSH and OPU groups were recovered as cumulus-oocyte 
complexes (COCs), from live cattle using transrectal ultrasound-guided oocyte aspiration, using 
methods described above in section 3.3.3. Cows were restrained in a manual squeeze chute, 
administered 30 mg xylazine im and given a 5mL, 2% lidocaine epidural. Ovaries were palpated 
rectally and held against the vaginal wall so follicles could be visualized on ultrasound and 
aspirated using the aide an ultrasound probe that had been inserted vaginally. Once visualized, all 
follicles greater than three mm in diameter were aspirated. Follicular fluid was aspirated directly 
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5.3.3 Super stimulation 
Cows assigned to superstimulation were subjected to a dominant follicle removal (DFR) 
where all follicles greater than 6mm in diameter were ablated, using the same methods described 
below for transvaginal ultrasound-guided follicle aspiration (TUGA). This ensured all cows were 
in the follicular growth phase at the start of the stimulation program. Five mL of prostaglandin 
F2α  (Lutalyse® , dinoprost tromethamine, 25mg, Zoetis Inc, Kalamazoo, MI, USA ) was 
administered intramuscularly (im) to lyse any corpora lutea present, and an intravaginal 
progesterone releasing device was inserted (Eazi-BreedTM CIDR® , Zoetis Laboratories, 
Kalamazoo, MI, USA). Cows were administered follicle stimulating hormone (FSH, 
Folltropin® -V, Bioniche Animal Health, Athens, GA, USA) im every twelve hours for a total of 
six doses, beginning 36 hours after DFR. A constant dose schedule was used with injections of 
1.7 mL each to a total of 200mg FSH per cow (20mg/mL). Twenty-four hours after the last FSH 
injection CIDRs were removed, and oocyte retrieval was performed 24 hours after CIDR 
removal, allowing a 48-hour coasting period between the last FSH injection and oocyte recovery 
(Figure 5.1).  
Fi e 5.1. Sc ule used for the stimulation protocol.  
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into a 50mL FalconTM tube that had been primed with collection medium. The aspiration system 
was rinsed with collection medium after each ovary to prevent oocytes from being held in the 
aspiration lines.  Once recovered, oocytes were placed in Hepes-TALP at 38.5°C, transported 15 
minutes to the lab and held briefly until further processing. The total number of oocytes 
recovered was recorded as well as their visible grade, based on cumulus cell enclosure and 
cytoplasm appearance (Appendix). All oocytes from a single day were pooled at the end of the 
recovery process, and were then randomly separated into cohorts for each analysis method. 
For post-mortem collection of oocytes, ovaries were harvested at a local abattoir 
following slaughter of cows. They were stored in an insulated cooler to maintain temperature for 
a maximum of two hours before being transported 15 minutes to the laboratory. On arrival at the 
laboratory, ovaries were trimmed and rinsed three times with warmed saline. All visible follicles 
were then aspirated by inserting an 18-guage, 1.5 inch needle connected to a vacuum line. Lines 
containing follicular fluid were rinsed with Dulbecco’s phosphate buffered saline to ensure 
oocytes were recovered from the collection lines. Once recovered oocytes were rinsed and 
moved directly to treatment. 
Oocytes from all three retrieval methods that were assigned to analysis at the GV stage 
were denuded of cumulus cells by vortexing for two minutes in 200µL of BO-Wash (IVF 
Biosciences product #61008) and were snap-frozen as per methods outlined below in section 
5.3.6 immediately following initial processing.  
5.2.5 Oocyte Maturation and Embryo Culture 
Oocytes from both OPU and super-stimulation collection methods (that were assigned to 
treatments requiring maturation) were rinsed three times in IVM medium (Appendix) before 
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being transferred in groups of 10-12 to fresh 35µL droplets of IVM medium under oil. They were 
then cultured for 22 hours in a humidified incubator at 38.5°C and 5% CO2.  
Post-mortem recovered oocytes were purchased from a commercial source and shipped in 
for further processing. Those assigned to treatments requiring maturation were rinsed three times 
before being transferred in groups of 50 to a 2mL FalconTM tube containing IVM medium, that 
had been gassed and equilibrated under 5% CO2 They were then transported overnight in a 
portable incubator (MiniTube product#19180/0001)  and maintained at a constant temperature of 
37°C. On arrival in our laboratory, they were transferred to a humidified incubator at 38.5°C, 
under 5% CO2 for the remainder of the 22 hour maturation period.  
Oocytes from all three treatment groups that were assigned to RNA-Seq at the MII stage 
were then denuded and snap frozen following protocols outlined below in section 5.3.6. The 
remaining oocytes were used for embryo culture. Oocytes were rinsed three times in drops of 
BO-IVF medium (IVF Biosciences, product #61003) before being transferred in groups of up to 
50 to fresh 450µL wells of BO-IVF. Meanwhile, a single 0.25mL straw of frozen semen from a 
bull of proven fertility was thawed by brief submersion of the sealed straw in a 37°C water bath 
and prepared for insemination. Thawed semen was transferred to a 15mL conical tube containing 
2mL of BO-Semen prep (IVF Biosciences, product #61004) and centrifuged for 5 minutes at 
400G. The sperm pellet was removed, resuspended in 2mL of fresh BO-Semen prep and again 
centrifuged for 5 minutes at 400G. The final sperm pellet was resuspended in ~500mL of fresh 
BO-Semen prep to a final concentration of 4.0x106/mL. Fifty microliters of sperm suspension 
was then aded to each droplet containing oocytes for embryo production. Oocytes and sperm 
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were cultured together in BO-IVF in a humidified incubator at 38.5°C under 5% CO2 for 18 
hours in in vitro fertilization (IVF). 
Following fertilization, cumulus-oocyte complexes were moved to 200µL of 1mg/mL 
hyaluronidase and vortexed for 2 minutes to remove all of the surrounding cumulus cells. 
Denuded oocytes were then rinsed three times in Hepes-Talp, and washed through three droplets 
of BO-IVC medium (IVF Biosciences, product #61001) before being transferred to a fresh drop 
of BO-IVC under oil (BO-Oil, IVF Biosciences, product #6200) and returned to the incubator. 
Presumptive embryos were checked on day-2, day-4 and day-7 following fertilization and 
embryo development was recorded.  
5.2.6 RNA Sequencing 
Both GV and MII oocytes from all three collection methods were subjected to the same 
RNA-Seq protocols. Immediately following completion of oocyte collection (GV) or IVM (MII), 
oocytes were denuded of all cumulus cells by vortexing for two minutes in 200µL of BO-Wash 
(IVF Biosciences product #61008). Denuded oocytes were rinsed three times in BO-wash and 
twice in PBS+1%BSA (Appendix). They were then transferred in pools of four oocytes to 1.5mL 
microcentrifuge tubes, in a total volume of 2µL of PBS per tube. Oocytes were snap frozen and 
maintained at -80°C until completion of RNA-Seq.  
Thawed oocytes were dissociated in lysis buffer and cDNA libraries were prepared using 
SMART-Seq v4 (Takara Bio USA) following manufacturers guidelines (Appendix) (Petropoulos 
et al., 2016). Following oocyte lysis, cDNA was synthesized first by ligation of the 3’ primer 
sequence, SMART-Seq CDS primer IIA, followed by  reverse transcription using SMARTScribe 
Reverse Transcriptase. Prepared cDNA was then amplified by 16 cycles of PCR using SeqAMP 
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DNA Polymerase and was purified using AMPure XP beads. Quality and quantity of cDNA was 
measured using Qubit 3.0 and quality was validated on an Agilent TapeStation. One hundred and 
fifty nanograms of cDNA was tagmented and sequencing libraries were prepared using a Nextera 
XT DNA library preparation kit (Illumina) and multiplexed by Nextera XT Index kit (Illumina). 
Finally, sequencing libraries were purified by AMPure XP beads, and quantified by Quibit 3.0 
and TapeStation for measurement of concentration and size distribution. Indexed libraries were 
diluted to 4nM and equal, pooled samples were sequenced on an Illumina NextSeq 500 Platform 
at Pennington’s Biomedical Research Center (Baton Rouge, LA, USA).  
5.2.7 Data Analysis 
RNA-seq reads were trimmed and aligned to the bovine reference genome (bosTau8) 
using STAR (2.5.3). Differentially expressed genes between different treatment groups were 
determined using DESeq2 package in R 5.0. In each comparison, genes were deemed 
differentially expressed if they showed a false discovery rate adjusted P-value <0.05 and a 
confident Log2-fold change (FC) >1. Gene ontology (GO) and Pathways analysis were 
performed using IPA (Ingenuity Pathway Analysis, Quiagen). 
Embryo production rates were compared across oocyte recovery methods using chi 
square analysis in RStudio. 
5.3 Results 
A total of 232 OPU, 238 FSH and 375 PM oocytes were recovered. Of which, 92 were 
used in pools of four, for RNA-Seq (4 replications for each treatment, 3 replications for MII 
PM). Three hundred and six were used in IVF, and the remaining oocytes have been maintained 
at -80°C for later analysis (Table 5.2).  
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Table 5.2. Number of samples allocated to each treatment. 
A total of 605.8 million raw sequencing reads that passed filtering were obtained and an 
average of 26.3 million read pairs per sample were generated (Appendix). Reads were largely of 
high quality, and in the majority of samples >90% of reads were correctly aligned to exons.  
During gene expression analysis, multi-dimensional scaling (MDS) plots were created to 
compare gene expression patterns between all samples (Figure 5.2). When assessed in two 
dimensions based on the biological coefficient of variation (BCV), samples were clearly broken 
into two groups with different gene expression patterns between immature and mature oocytes, 
regardless of treatment group. Within each maturation level, differences were less notable. There 
was a high degree of overlap in expression patterns between immature oocytes from all recovery 
methods. In in vitro matured oocytes, the oocytes collected following FSH stimulation had a 
different expression pattern from oocytes of either other retrieval method, with the exception of 
one OPU sample that was more similar to the FSH samples.  On further analysis, a heatmap was 
created, assessing only the ten most variably expressed genes (Figure 5.3). Of these ten genes, 
three are transmembrane proteins, two are involved in cytoskeleton polymer changes, one is a 
peptidase and one is a glutathione transferase.  Based on expression of these genes, oocytes were 
largely clustered in groups by both maturation level and collection method, with only a few 
samples having expression patterns dissimilar to others within their treatment. Again IVM 
oocytes collected following super-stimulation were on a different hierarchical branch than the 
Collection Method Germinal Vesicle Metaphase II Embryo Production
Oocyte Pick-up 4 4 66
Super-stimulation 4 4 80
Post-mortem 4 3 160
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majority of the other recovered oocytes, suggesting a high degree in difference in transcript 
abundance. 
Figure 5.2. MDS plot depicting overall differences in gene expression patterns between 
individual samples of pooled bovine oocytes classified by oocyte recovery method and 
maturation level.  
Oocytes within each recovery method exhibited a characteristic change in gene 
expression over the course of maturation. Nearly 6000 genes had altered expression between 
germinal vesicle (GV, immature) stage and metaphase II (MII, mature) oocytes, within each 
treatment, with the majority having higher transcript abundance following maturation. However, 
once genes were filtered based on both significance (FDR P<0.05) and >2-fold difference in 
expression between groups, this pattern changed. Only ~2000 genes per collection method met 
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these qualifications, and among them there was a roughly even split between up- and down-
regulation (Figure 5.4). There was a slight preference for transcript abundance to be increased in 
mature oocytes that was most notable in those oocytes recovered following FSH stimulation.  
When complete pathway analysis was performed, the pathways most affected by maturation 
were those involved in energy production, as was especially true of FSH oocytes.   
Figure 5.3. Heatmap showing relative expression levels of the ten genes that were the most 
variable in expression level between samples. Oocyte hierarchical clustering, shown along the 
top, is based on similarity on expression patterns for these ten genes.  Yellow indicates low 
expression and Red indicates high expression. 
Gene expression differences were also compared between oocytes from the different 
recovery methods within each maturation level. Using only those genes that had a two-fold or 
greater difference in expression, which were calculated as significantly differentially expressed 














































































oocytes where 67 genes were up-regulated in PM oocytes compared to OPU, and 105 were 
down-regulated (Figure 5.5).  Meanwhile, between OPU and FSH oocytes, no genes were 
significantly up-regulated in FSH, and only 12 were down-regulated. In the PM:FSH comparison 
20 genes were up-regulated in FSH oocytes and 35 were down-regulated. Of those genes that 
were significantly different, the most significantly affected pathways were primarily related to 
the TCA cycle and ATP synthesis, GnRH receptor pathway and TGF-ß signaling. The OPU:PM 
comparison also showed a significant difference in the activity of multiple genes (28) regulating 
the zona pellucida and fertilization, all of which had decreased transcript abundance in OPU 
oocytes (FDR P<0.05).  Genes regulating mitochondrial and organelle structure were found in 
greater abundance in OPU oocytes than FSH oocytes (FDR P<0.05). 
Figure 5.4.  The change in gene expression within each oocyte recovery method over the course 
of in vitro maturation. Approximately 2000 genes change expression within each treatment 
group. In OPU oocytes there is a relatively even split between up- and down-regulated genes, 

















Figure 5.5. Comparison of gene expression in germinal vesicle stage bovine oocytes recovered 
by three different methods. 
As oocytes matured, the relative gene expression patterns changed rather dramatically 
(Figure 5.6). In the comparison between OPU:PM oocytes the apoptosis signaling pathway was 
significantly up-regulated in OPU oocytes, as were genes controlling mitochondria and organelle 
function, and the electron transport chain. In the FSH:PM comparison there was a significant 
increase in the expression of genes involved in the TCA cycle, ATP synthesis, glycolysis and the 
pentose phosphate pathway in FSH oocytes. Similarly, in the comparison between FSH and OPU 
oocytes, FSH oocytes had increased transcript abundance for genes controlling the TCA cycle, 
ATP synthesis, cellular metabolism and the cell cycle but decreased abundance of transcripts 
involved in control of organelle structure and function (FDR P<0.05). In all, only 46 genes had 
significantly different expression between OPU and PM oocytes (13 up-regulated and 33 down-
regulated in PM oocytes), while 296 genes had significantly different expression between OPU 
and FSH oocytes (269 up-regulated and 27 down-regulated in FSH), and 307 were differentially 
expressed between PM and FSH (305 up-regulated and 2 down-regulated in FSH). 
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Up-regulated in PM oocytes
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Figure 5.6. Comparison of gene expression in metaphase II bovine oocytes recovered by three 
different methods. 
Embryo cleavage rates were relatively low especially in OPU oocytes, ranging from 11% 
to 29% of oocytes (Table 5.3). Following cleavage, the majority of embryos in FSH and PM 
recovery groups continued to develop to the morula stage, while OPU oocytes had decreased 
developmental rates, with a high proportion being arrested at the 2- and 4-cell stages (5/7 
arrested, compared to only 3/20 for FSH and 8/46 PM). There was a significant difference in 
embryo development rates (P<0.01) at the morula stage, with embryo development being 
decreased in OPU oocytes, compared to those retrieved by other means. On day-7 when 
blastocyst rate was recorded, there was a significant effect of recovery method on the blastocyst 
rate, although development rates were low across the board, ranging from 2% from OPU to 14% 
from FSH and 17% from PM oocytes (P<0.01). However, when blastocyst development rate was 
calculated as the proportion of cleavage stage embryos that continued to develop, the recovery 
method was found to have a more notable effect. With only 14% of cleaved zygotes developing 
to blastocysts following OPU, but 55% following FSH and 59% following PM retrievals, 
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conventional OPU was found to have significantly decreased embryo production rates 
(P=0.0067) than either of the other two retrieval methods.  
Table 5.3. Embryo production rates as affected by bovine oocyte retrieval method. Superscripts 
denote significant differences between values within a column (P=0.0067). 
5.4 Discussion 
There have been discrepancies in the literature on the effect of follicle atresia on oocyte 
competence, with reports suggesting atresia could have anywhere from a positive effect, or no 
effect to a strongly negative one (Blondin and Sirard, 1995). However, while follicle atresia has 
not been found to be conclusively correlated with oocytes of decreased competence, oocytes 
collected during the follicular growth phase, when atresia is not present, have been shown to 
result in more competent oocytes and production of a greater number of overall high quality 
blastocysts (Hagemann et al., 1999). One suggestion from previous studies is that collecting 
oocytes from early atretic follicles results in the highest blastocyst production rate, while 
collection from late atretic follicles yields oocytes of decreased competence (Moor and 
Trounson, 1977; Blondin and Sirard, 1995). The premise that early atresia can be beneficial has 
been seen in collecting both post-mortem oocytes and those following super-stimulation. During 
the period between cow death, harvesting ovaries and recovering oocytes from the ovaries, 
physiological processes mimicking atresia occur, having a beneficial effect on oocyte 
competence for the first four hours post mortem and an increasingly negative effect thereafter 
Collection 
Method n Cleavage (%) Morula (%) Blastocyst (%)
% Blastocysts by 
Cleaved
Oocyte Pick-up 66 7 (11%) 2 (3%) 1 (2%) 14%A
Super-
stimulation 80 20 (25%) 17 (21%) 11 (14%) 55%
B
Post-mortem 160 46 (29%) 38 (24%) 27 (17%) 59%B
 !72
(Blondin et al., 1997). In ovum pick-up following super-stimulation, it is common to allow a 
coasting period following the last FSH injection prior to oocyte collection. This causes the 
follicles to undergo FSH starvation and to initiate atresia, improving both oocyte competence and 
yield for the first 48-60 hours of coasting and resulting in declining developmental competence 
thereafter.  
In the current study, both FSH super-stimulation and post-mortem oocyte collection 
resulted in increased embryo production compared to oocytes collected following conventional 
OPU, in agreement with this theory. However, de Witt et al. (2000) show evidence that the 
reasoning behind this apparent improvement in competence is that a greater proportion of 
oocytes collected from these follicles had a strong cumulus cell investment, perhaps because the 
atretic cells of the follicle had more easily loosened connections with the cumulus-oocyte 
complexes (COCs). Oocytes collected via OPU during the current project had a decreased 
cumulus investment, resulting in an overall decreased grade compared to oocytes recovered by 
other methods (77/232, 136/228 and 360/375 “A” grade oocytes from OPU, FSH and PM, 
respectively. Furthermore, perhaps because of the poor cumulus cell support, oocytes collected 
by OPU showed the poorest maturation rates. It is possible that this is the primary reason for 
failed fertilization in the OPU group oocytes presented above, supporting the hypothesis that the 
ease of removing highly competent COC’s from early atretic follicles may play a major role in 
improving oocyte developmental competence. 
It was found that genes involved in energy production and mitochondrial function were 
among those most differentially expressed between the different treatments, especially following 
in vitro maturation. It is accepted that oocyte energy production is important to early embryo 
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survival, and that irregularities in oocyte mitochondrial function can lead to decreased 
developmental rate. In addition, the genes involved in metabolism have been shown to be 
amongst those, most differentially expressed between fast and slow developing blastocysts, 
indicating that there is significant correlation between the ability of an embryo to produce energy 
and its developmental potential (Ispada et al., 2018). Although by the blastocyst stage, the genes 
involved in energy production are of the embryonic genome, this is indicative of the importance 
of energy production to embryo development and the issues of delayed development that may 
occur as a result of even minor aberrations. The design of this study did not allow for comparison 
to in vivo matured oocytes to determine which had the most normal gene expression patterns but 
the sheer frequency of differences of metabolic gene expressions between oocytes at the same 
maturational levels is indicative that the different follicular dynamics and handling methods 
involved in the different oocyte retrieval methods are causing metabolic stress on oocytes. The 
fact that these differences are maintained, despite oocytes being matured in similar 
environments, indicates that the alterations in gene expression are lasting and may have long-
term implications in embryonic and fetal development.   
One study assessing the differences between immature and in vitro matured oocytes 
found that there were a total of 2117 differentially expressed genes, of which 1528 were down-
regulated following maturation, and 589 were up-regulated (Mamo et al., 2011). Of these, the 
majority of the over-expressed genes were involved in pathways related to cell growth and 
development, molecular transport, protein synthesis and embryo development (Mamo et al., 
2011). Other studies have corroborated the effects of IVM on altering oocyte gene expression, 
interfering with pathways involved in meiotic and mitotic progression and embryonic 
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development (Eppig et al., 1994; Trounson et al., 2001; Combelles et al., 2002). In comparison to 
the present study, in which all oocytes were matured in vitro but were recovered through 
different methods, the most frequently aberrantly expressed gene pathways were primarily 
related to metabolism, and mitochondrial function. However, few other studies have been 
published looking at similar effects to act as direct comparisons to this work. Results of the 
current study are in agreement with past studies in that there is a high degree of change in gene 
expression between GV and MII oocytes. It is generally expected that the majority of genes 
should be down-regulated over the course of maturation. The lack of genome silencing that was 
seen in OPU oocytes in this study may be an indication that either oocytes were of poor 
developmental competence of that molecular maturation was incomplete. This is in agreement 
with the poor embryonic development that was seen in oocytes, especially those recovered by 
conventional OPU.  
Initially, in GV oocytes both OPU and FSH oocytes were found to have remarkably 
similar gene expression to each other, suggesting that the stimulation protocol had no major 
effects on molecular development within oocytes. However, PM and OPU oocytes had different 
expression patterns, with post-mortem collected oocytes having more active expression than 
those collected via OPU. It is possible that the higher degree of metabolic activity in oocytes 
collected post-mortem allows for increased energy stores, improving embryo competence even if 
the genes are later silenced. It is believed that some of the proteins required for GVBD are only 
synthesized in vivo just prior to ovulation, and are not present in antral follicles 2-8 mm 
(Bilodeau-Goeseels, 2012). However, many other proteins and mRNAs required for embryonic 
development are acquired prior to oocyte maturation, during oocyte growth and folliculogenesis 
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(Minami et al., 2007; Wrenzycki et al., 2007) and so should not differ in expression levels 
between highly competent immature and mature oocytes. However, because there was less 
control in the size of follicles collected by OPU than by either of the other two methods, it is 
possible that OPU oocytes would have different gene expression patterns by not having 
completed this stage of oocyte development, and that this difference is not necessarily indicative 
of competence.  
By completion of MII the pattern of gene expression differences between the collection 
methods had changed notably from that seen in immature oocytes. In mature oocytes, OPU and 
PM oocytes had similar gene expression levels, while FSH oocytes were significantly more 
actively transcribing genes than oocytes from either of the other two collection methods, with 
over 200 genes over-expressed compared to each of OPU and PM recovered oocytes. Since MII 
oocytes are accepted as being transcriptionally quiet compared to GV oocytes, this high level of 
gene expression in FSH oocytes could be indicative of failure to complete molecular maturation. 
However, an alternate theory is possible. RNA sequencing is based on the presence of mRNA 
transcripts, which are normally short-lived within somatic cells. However, in oocytes mRNA is 
produced during folliculogenesis and maturation and is then stored for a period of days to 
support life-sustaining functions in the early embryo, prior to the initiation of transcription of the 
embryonic genome (Sirard et al., 2006a; Watson, 2007). Based on this premise, it is feasible that 
oocytes of the highest competence, which have successfully completed meiotic maturation, will 
have large mRNA stores. It is possible that these oocytes will artificially appear to be actively 
transcribing genes that instead have mRNA stored from prior transcription. In this case apparent 
gene up-regulation could be an indication of competence in MII oocytes, a theory that is 
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corroborated by the fact that FSH oocytes that had the highest gene expression levels at MII also 
had the highest embryo production rates.  
A third possibility to specifically explain the increased abundance of transcripts involved 
in energy regulation found in oocytes recovered following super-stimulation is the concept that 
highly competent, and perhaps also highly competent oocytes, undergo a shift in glucose 
metabolism away from the tricarboxylic acid cycle (TCA) and towards the pentose phosphate 
pathway (Richard and Sirard, 1996; Krisher and Prather, 2012). This metabolic shift coupled 
with overall increased glucose metabolism, mimicking the Warburg effect, could increase the 
production of nucleic acids and fatty acids, both necessary for the rapid cell division and 
development which occur during early embryogenesis (Wakefield et al., 2011). Previous studies 
have shown the benefit of cells exhibiting the Warburg effect towards early embryo 
development, and since blastomeres at this stage of development are transcriptionally quiescent, 
it is reasonable that increased transcription of genes involved in these processes would be 
necessary prior to the completion of oocyte maturation. As such, it is possible that the oocytes 
recovered in this study, following super-stimulation may be exhibiting increased transcript 
abundance in accordance with the Warburg effect and so may be of higher developmental 
competence than oocytes recovered by either unstimulated OPU or those retrieved post-mortem. 
Further studies are warranted to determine the metabolic activity and lasting effects of any 
differences found in these super-stimulated oocytes.  
In all, it is evident that, be it beneficial or detrimental, oocytes recovered following super-
stimulation have high levels of RNA transcripts present at the MII stage that are not present in 
MII oocytes collected post-mortem of by unstimulated OPU. These oocytes, however, have a 
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very similar gene expression profile at the GV stage to oocytes collected by OPU. This suggests 
that if stimulation has an effect on oocyte genome regulation, it is one that is more visible later in 
development though potentially with lasting metabolic effects on the fetus. Meanwhile, oocytes 
recovered post-mortem have only slightly irregular gene expression at the GV stage, but this 
effect does not seem to be permanent and oocytes exhibit transcript profiles similar to those in 
oocytes retrieved by OPU following in vitro maturation.  
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CHAPTER VI 
THE EFFECT OF BOVINE OOCYTE RECOVERY METHOD ON 
OOCYTE ULTRASTRUCTURE 
6.1 Introduction 
In vitro maturation supports meiotic maturation of oocytes but is often reported as poorly 
stimulating cytoplasmic maturation, resulting in mature oocytes with poor developmental 
competence (Eppig et al., 1994; Combelles et al., 2002; Salamone et al., 2003; Schramm et al., 
2003; Jimenez-Macedo et al., 2006). In addition to the risk of in vitro maturation causing 
aberrations in cytoplasmic maturation, there is also the possibility that superstimulation can be 
disruptive to oocyte development, causing abnormal organelle bahavior (Lee et al., 2006; Zeng et 
al., 2009; De los Reyes et al., 2011). The accelerated growth rates imposed on follicles by high 
doses of follicle stimulating hormone cause aberrations in the external hormonal milieu in which 
oocytes are developing. This results in accelerated oocyte development at the risk of missed 
developmental steps and the accruement of abnormalities, most especially amongst the 
cytoplasmic changes that occur during development in preparation for oocyte cytoplasmic 
maturation. This can be largely detrimental to embryo production rates as the reorganization of 
organelles and storage of mRNA, proteins and transcription factors involved in cytoplasmic 
maturation ensures the proper distribution and cytoplasmic dynamics necessary to activate the 
oocyte for fertilization and to support embryonic development (Sirard et al., 2006b; Watson, 
2007). Meanwhile, follicular atresia, such as that seen in ovaries collected post mortem, has been 
shown to be potentially beneficial to oocyte competence, but the mechanism and the effects on 
oocyte cytoplasmic maturation ability are as of yet undetermined (Blondin and Sirard, 1995; 
Blondin et al., 1997). 
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The importance of completed cytoplasmic maturation for oocyte competence has been 
well established and has been broken down into three distinct aspects; molecular maturation, and 
the reorganization of cytoskeletal polymers and of the organelles. However, many aspects of 
cytoplasmic maturation have proven difficult to characterize, and among those that are well 
characterized the relative importance of each factor is uncertain. Although many of the 
differences that occur in in vitro matured oocytes compared to their in vivo matured counterparts 
are known, the effects that the different oocyte recovery methods have on these differences are as 
yet unclear. Since it is believed that follicular environment plays a significant role in driving 
oocyte development, it stands to reason that oocytes collected from under the influence follicles 
with different, unnatural, dynamics may have notable differences in their own developmental 
characteristics.  
The current study was designed to use transmission electron microscopy to examine the 
effect of three major bovine oocyte retrieval methods (traditional OPU, super-stimulation 
followed by OPU, and oocyte recovery post-mortem) on the ultrastructure of immature oocytes. 
The ability of oocytes recovered from each method to complete cytoplasmic maturation in vitro 
will then also be assessed and compared, assessing the same cytoplasmic parameters. Although 
this study was designed to be descriptive in nature, it was hypothesized that 1) organelle 
distribution and reorganization would follow patterns characteristic of bovine oocytes. 2) Super-
stimulation would result in irregularities in oocyte ultrastructure compared to other oocyte 
recover methods.   
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6.2 Methods 
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich Chemical Co. 
(St. Louis, MO, USA). 
6.2.1 Animals 
All procedures in this experiment were approved by the Louisiana State University 
Agricultural Center’s Institutional Animal Care and Use Committee and were carried out at the 
LSU Reproductive Biology Center, St. Gabriel, LA, USA. Thirty mixed breed beef cows, housed 
on pasture with ad libitum access to mixed native grasses supplemented with hay and full access 
water were used for oocyte collections through October and November of 2017. 
6.2.2 Experimental Design 
Oocytes were collected via three different collection methods in an attempt to determine 
if the oocyte source affects the ultrastructure of oocytes. Because they are the three most 
commonly employed methods of oocyte retrieval in bovine IVP research, oocytes were collected 
from live cows via ovum pick-up either at random time points in the estrous cycle (OPU), or 
following a super-stimulation protocol (FSH), and oocytes were retrieved post-mortem from 
abattoir derived ovaries (PM). Recovered oocytes from all three treatments were then randomly 
allocated to one of two treatment groups, where they were either fixed immediately at the 
germinal vesicle (GV) stage, or matured in vitro to the metaphase II (MII) stage and then fixed. 
All groups of fixed oocytes were subjected to the same protocols and were analyzed by 
transmission electron microscopy to determine ultrastructural differences between groups. This 
study was specifically designed to analyze differences in cortical granule location, mitochondrial 
structure and location, lipidation levels, and vesicle locations and amount. 
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This project was designed as a preliminary, descriptive study only. 
6.2.3 Super-stimulation and Oocyte Retrieval 
Cows assigned to super-stimulation were subjected to a dominant follicle removal (DFR) 
where all follicles greater than 6mm in diameter were ablated, using the same methods described 
below for transvaginal ultrasound-guided follicle aspiration (TUGA). Super stimulation followed 
the same protocols as those outlined in section 5.3.3. A CIDR®  (Zoetis Laboratories, USA) was 
inserted at the time of DFR and beginning 36 hours later, cows were administered Folltropin®  
(Bioniche Animal Health, Athens, GA) im every twelve hours for a total of six doses (200mG). 
Twenty-four hours after the last FSH injection CIDRs were removed, and oocyte retrieval was 
performed 24 hours after CIDR removal, allowing a 48-hour coasting period between the final 
FSH injection and oocyte recovery. 
Oocytes collected via either stimulated OPU or traditional OPU were recovered as 
cumulus-oocyte complexes (COCs), from live cattle using TUGA, using methods described 
above in section 3.3.3. Cows were restrained in a manual squeeze chute, administered 30 mg 
xylazine intramuscularly and given a 5mL, 2% lidocaine epidural. Ovaries were palpated rectally 
and held against the vaginal wall so follicles could be visualized on ultrasound and aspirated 
using the aide of an ultrasound probe that had been inserted vaginally. Once visualized, all 
follicles greater than three mm in diameter were aspirated. Follicular fluid was aspirated directly 
into a 50mL FalconTM tube that had been primed with collection medium. The aspiration system 
was rinsed with collection medium after each ovary to prevent oocytes from being held in the 
aspiration lines.  Once recovered, oocytes were placed in Hepes-TALP at 38.5°C until further 
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processing. The total number of oocytes recovered was recorded as well as their visible grade, 
based on cumulus cell enclosure and cytoplasm appearance (Appendix). 
For post-mortem collection of oocytes, ovaries were harvested at a local abattoir 
following slaughter of cows. They were stored in an insulated cooler to maintain temperature for 
a maximum of one hour before being transported 15 minutes to the laboratory. On arrival at the 
laboratory, ovaries were trimmed and rinsed three times with warmed saline. All visible follicles 
were then aspirated by inserting an 18-guage, 1.5 inch needle connected to a vacuum line. Lines 
containing follicular fluid were rinsed with Dulbecco’s phosphate buffered saline to ensure 
oocytes were recovered from the collection lines. Once recovered oocytes were rinsed and 
moved directly to treatment. 
6.2.4 Oocyte Maturation 
Oocytes from both OPU and super-stimulation collection methods (that were assigned to 
treatment requiring maturation) were rinsed three times in IVM medium (Appendix) before 
being transferred in groups of 10-12 to fresh 35µL droplets of IVM medium under oil. They were 
then cultured for 22 hours in a humidified incubator at 38.5°C and 5% CO2.  
Post-mortem recovered oocytes were purchased from a commercial source and shipped 
for further processing. Those assigned to treatments requiring maturation were rinsed three times 
before being transferred in groups of 50 to a FalconTM tube containing 2mL of IVM medium, that 
had been gassed and equilibrated under 5% CO2 They were then transported overnight in a 
portable incubator (MiniTube) and maintained at a constant temperature of 37°C. On arrival in 
the laboratory, they were transferred to a humidified incubator at 38.5°C, under 5% CO2 for the 
remainder of the 22 hour maturation period.  
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Following the completion of maturation, oocytes from all treatment groups were washed 
in BO-Wash (IVF Biosciences product #61008) before being vortexed in 200µL of BO-wash to 
remove cumulus cells. Oocytes were rinsed two times in fresh BO-wash and two times in 0.1M 
phosphate buffer (Appendix) before beginning fixation for electron microscopy.  
6.2.5 Fixation and Electron Microscopy 
Oocytes were fixed and prepared for transmission electron microscopy following 
minimally modified methods previously published (Appendix) (Hyttel et al., 1986; Hyttel and 
Madsen, 1987). Oocytes were initially fixed in a 3% glutaraldehyde solution before being 
embedded individually in 2 mm cubic blocks of 4% agar. They were then post-fixed 1% osmium 
tetroxide for one hour at room temperature, before being washed and stained for one hour in 
0.5% uranyle acetate in the dark, at room temperature. Oocytes were washed twice in water 
before being dehydrated in five step-wise increasing concentrations of ethanol from 50% to 
100%. Alcohol was removed from blocks by incubation in propylene oxide prior to embedding 
in epon-araldite resin. Epon polymerization was gradual over three days with a 24-hour 
incubation at each of 24°C, 37°C and 60°C. Following polymerization, resin blocks containing 
the oocytes were trimmed and oocytes were cut into ultra-thin sections that were stained with 
uranyle acetate and lead citrate. Sections were mounted on copper grids and examined on a 
Transmission Electron Microscope (JEOL 2011 TEM, JEOL USA, Peabody, MA, USA, 
equipped with a Gatan SC10000 CCD camera, Gatan Inc, Warrendale, PA, USA). 
6.3 Results 
A minimum of two oocytes were analyzed from each treatment group, and a minimum of 
three sections of each oocyte was assessed at each two different levels within the ooplasm. 
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Results within an oocyte did not appear to show marked differences between imaging sites with 
regard to organelle and oolemma characteristics of note.  However there were some apparent 
differences between both collection methods and maturational status (Table. 6.1). 
In the majority of oocytes, microvilli densely covered the extracellular surface of the 
oolemma, projecting towards the zona pellucida. In oocytes collected via OPU, both immature 
and mature oocytes had a large number of long, thin microvilli, relatively evenly distributed over 
the oolemma. Oocytes collected from post mortem ovaries and from OPU following super-
stimulation exhibited similar patterns among the microvilli of matured oocytes as that seen in 
OPU oocytes. However, immature oocytes collected via these methods both had a decreased 
density of microvilli, and those microvilli that were present appeared to be shorter and found 
only in clusters on the oolemma.  
Cortical granules were found more frequently in in vitro matured oocytes than in 
immature oocytes, regardless of retrieval method employed. However, in both methods of 
recovery from live cattle, even immature oocytes had sparse cortical granules present. In matured 
oocytes recovered from abattoir-derived ovaries, or following traditional OPU, cortical granules 
were found in a single, relatively continuous row directly below the oolemma (Figure 6.1). 
However, oocytes collected following stimulation exhibited an aberrant pattern, whereby 
immature oocytes presented a single sub-oolemmal layer of cortical granules, but mature oocytes 
were found instead to have peripheral clusters of cortical granules (Figure 6.2).  
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Table 6.1. Ultrastructural differences observed in immature and mature bovine oocytes collected 
through different retrieval methods. 
 
Figure 6.1. Transmission electron microscope image of an immature bovine oocyte. 1. Micovilli 
are long and thin but are relatively sparse. 2. Mitochondria are found primarily in the peripheral 
region of the ooplasm. 3. Cortical granules are present in large clusters in the peripheral region of 
the ooplasm. 4. Few mitochondria are scattered in small clusters throughout the cytoplasm. 5. 
Vesicles occupy the vast majority of the oocyte volume. 
 
Immature Oocytes Mature Oocytes
Characteristic OPU PM Stim OPU PM Stim
CG Number Rare None Rare Few Many Rare










Lipid Density Rare Rare Some Few Few Some
Mitochondrial 
Density













Strong Strong Strong Strong Medium Strong
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Figure 6.2. Transmission electron microscope image of an immature bovine oocyte collected 
post mortem. 1. Microvilli are sparse and those present are short. 2. Mitochondria are distributed 
evenly throughout the ooplasm. 3. Vesicles are present and many are in close proximity to 
mitochondria. 4. Lipids are present but do not occupy a large volume. 
While lipid concentrations were low in most oocytes, they were slightly more abundant in 
matured oocytes. Where present, lipids were found in close association with mitochondria, often 
as mitochondria-lipid clusters (Figure 6.3). Vesicles were also frequently found in close 
proximity with mitochondria. However, unlike lipids, vesicles were abundant in oocytes, 
occupying the vast majority of the ooplasm. This was especially true in immature oocytes, 
regardless of recovery method.  
Mitochondria were less abundant than expected across all recovery methods, and this did 
not change with maturation. Overall, mitochondrial numbers appeared to be the lowest in 
oocytes collected by unstimulated OPU. In addition to frequently being found in association with 
lipids and vacuoles, there were three primary mitochondrial distribution patterns found among 







mortem, mitochondria were frequently found to be either primarily or exclusively in the 
peripheral region (Figure 6.1). Immature post-mortem collected oocytes and in vitro matured 
oocytes recovered by all three methods frequently had mitochondria found in large clusters 
throughout the cytoplasm, most often in association with vacuoles, lipids and endoplasmic 
reticulum (Figure 6.3). Finally, select few immature oocytes collected via OPU, both with and 
without stimulation, exhibited mitochondria in a diffuse distribution with even distribution 
throughout the cytoplasm (Figure 6.2). This diffuse pattern was also found in two of the oocytes 
collected by unstimulated OPU following IVM.  
Figure 6.3. Transmission electron microscope image of an in vitro matured bovine oocyte. 1. 
Microvilli are long and thin, evenly distributed over the oolemma. 2. Cortical granules are 
present as a single sub-oolemmal layer. 3. Mitochondria are found in large clusters within the 
ooplasm, primarily in association with vacuoles and lipids. 
In oocytes of all collection methods, and both maturation levels mitochondria were 
primarily found to be in the hooded configuration. However, mitochondrial populations within 





combination of hooded mitochondria, and those more typical, spherical mitochondria. Spherical 
mitochondria were found with transverse cristae and also with only peripheral mitochondria. 
Similar in structure to the hooded mitochondria were the visualized vacuolated mitochondria and 
ring- or cup-shaped mitochondria. Finally, a portion of the mitochondria found were of irregular 
shapes, primarily with peripheral cristae only but otherwise lacking vacuoles to explain their 
misshapenness. There was no apparent pattern discovered for any one mitochondrial shape to be 
more prevalent in one treatment group. Of the irregularly shaped mitochondria were a small 
subset that appeared to be budding or undergoing asymmetrical division (Figure 6.5). These 
mitochondria were found in immature oocytes collected via both stimulated and unstimulated 
OPU and in in vitro matured oocytes that had been collected by OPU, but not in oocytes 
collected post mortem.  
Figure 6.4. Mitochondrial populations within oocytes were highly heterogenous. 1. Ring-shaped 
mitochondria. 2. Hooded mitochondria. 3. Irregularly-shaped mitochondria. 4. Spherical 
mitochondria with peripheral cristae only. 5. Vacuolated mitochondria. 6. Spherical mitochondria 
with transverse cristae. 
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Figure 6.5. Transmission electron images of budding-type mitochondria found in bovine oocytes 
collected by both stimulated (GV) and unstimulated (GV and MII) OPU. 
Cumulus cells had a very different ultrastructure from that of the oocytes (Figure 6.6). 
Mitochondria were found in high concentrations and were all oblong with transverse cristae. A 
high proportion of the cumulus cell cytoplasm was occupied by lipid, though it was not 
particularly associated with mitochondria. Finally, though Golgi networks occupied a minor 
portion of the ooplasm, they constituted a large portion of the volume of the cumulus cells. Golgi 









Figure 6.6. Transmission electron microscope image of a cumulus cell found in conjunction with 
a mature bovine oocyte. 1. Golgi networks are extensive and  found peripherally. 2. Lipids 
occupy a relatively large proportion of the cell volume. 3. Mitochondria are found clustered, are 
ovoid with transverse cristae.    
6.4 Discussion 
Transmission electron microscopy allows the benefit of defining multiple aspects of the 
oocyte’s ultrastructure simultaneously, without the limitation of interfering wavelengths from 
multiple stains. This allows us to gain the most possible information on the organelles and how 
their interactions with each other may be mediated by different treatments imposed on the 
oocytes. Analyses in this regard found that while oocytes collected from all three recovery 
methods had similarities to each other and to the expected ultrastructural organization, there were 
some key differences observed. 
Although immature PM oocytes were the only ones in which cortical granules (CGs) 
were not present, with regards to CG parameters FSH oocytes were discordant with oocytes of 





development and maturation and are normally initially found diffusely throughout the cytoplasm 
but in MII oocytes CGs should be found in one or two rows immediately below the oolemma and 
form a near-continuous layer due to their density (Hosoe and Shioya, 1997; Shahedi et al., 2013). 
This pattern held for oocytes recovered by OPU and post-mortem with density increasing over 
maturation concurrent to peripheral migration. However FSH oocytes were discordant in both 
regards. Mature oocytes assessed had no more CG visible than their immature counterparts and 
while CG were found peripherally in immature FSH oocytes, they were diffuse in the cytoplasm 
at MII.  
As an oocyte matures, mitochondria migrate from peripheral distribution to a general 
dispersed distribution (Hyttel et al., 1986) before becoming granulated and finally clustered in 
areas requiring high ATP levels (Wang et al., 2009; Matchatkova et al., 2012). One characteristic 
of oocyte maturation is that mitochondria migrate to areas of high energy consumption to 
improve efficiency (Mau et al., 2014).  Oocytes in this project, both within and between groups, 
were highly variable in regards to mitochondrial location. The general pattern exhibited, with the 
exception of FSH oocytes, was for peripherally located mitochondria to be most frequently seen 
in immature oocytes and for mitochondrial clusters to be more common following maturation. 
Oocytes recovered following super-stimulation displayed mitochondrial clusters in both GV and 
MII stage oocytes, suggesting a higher degree of mitochondrial maturation was possible during 
follicular growth. However, the fact that oocytes with peripherally located mitochondria were 
only found in MII oocytes of the FSH group indicates that this advanced development is not 
pervasive, and in fact it is likely that mitochondrial development is highly variable within these 
oocytes. 
 !92
It is anticipated that both lipid and vesicle concentrations increase over the course of 
maturation in healthy oocytes, and both should be found in complexes with mitochondria 
(Thibault et al., 1987; Shahedi et al., 2013). Vesicle numbers, in particular, are high in in vitro 
matured oocytes when compared to in vivo matured oocytes (Thibault et al., 1987). Although 
lipid levels were low in all oocytes assessed in this project, this pattern did hold true, though less 
notably for FSH oocytes. Vesicles occupied the vast majority of the oocyte volume in most 
oocytes. However, oocytes from all retrieval methods had the highest vesicle volume prior to 
maturation. This suggests that the Golgi network had already been largely dissociated by the time 
oocyte retrieval was performed, which was corroborated by the fact that few Golgi apparatuses 
were noted. Lipid was exclusively found in mitohondria-lipid aggregates, suggesting 
metabolically active oocytes. High metabolic activity may be one explanation for low lipid levels 
visible, if oocytes had already metabolized lipid stores. However, low lipid levels before 
fertilization indicate poor competence in bovine oocytes since lipid stores are heavily used for 
energy production of embryos. Mitochondria-vesicle aggregates were also commonly found, 
especially in oocytes with clustered mitochondria, where the clusters would often form around 
vesicles. 
As mitochondria aggregate into larger clusters, especially those surrounding lipids, ATP 
production is increased (Yu et al., 2010). This was commonly seen in oocytes here, especially 
following maturation, indicating high ATP production of MII oocytes from all recovery methods. 
However, it is believed that stimulation results in oocytes with impaired mitochondrial function 
(Mau et al., 2014). While mitochondrial activity was not measured in this study, both the quantity 
of mitochondria and the mitochondrial structures were in line with those seen in oocytes from 
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other collection methods. However, mitochondria in this project did show some structural 
differences that have not been described in the bovine before, which may be indicative of 
irregular function. Previous work has reported that hooded, vacuolated and ring-shaped 
mitochondria, as were seen in the current work, are frequent in bovine oocytes, in addition to the 
more normal spherical mitochondria (Hyttel and Madsen, 1987; Reader et al., 2017). It is 
probable that the ring-shaped, vacuolated, and some of the irregularly shaped oocytes are in fact 
hooded mitochondria that have been transected at different angles and planes of the 
mitochondrion (Senger and Saake, 1970). As such, it is likely that most of the mitochondria 
viewed in the current study, were actually hooded mitochondria. The hood is believed to be a 
method of increasing mitochondrial surface area to increase energy production (Senger and 
Saake, 1970). This would suggest that oocytes containing increased proportions of hooded or 
irregularly shaped mitochondria may be of greater competence than those containing primarily 
spheroid mitochondria. Oocytes in all treatments in the current study were found to contain a 
large proportion of hooded mitochondria, but the irregularly shaped mitochondria were most 
frequent in super-stimulated oocytes. This may be a factor of bisecting hooded mitochondria at 
different planes, or it may be a function of the exogenous hormones disrupting the oocyte growth 
phase and disturbing mitochondrial development and structure. 
Some of those irregularly shaped mitochondria, found in both immature and mature 
oocytes collected from live cattle only, appeared to be in the process of budding. As 
mitochondria do undergo a massive increase in quantity during oocyte growth and early 
development, it is possible that these “budding” mitochondria are a sign of oocytes being 
recovered from small follicles prior to the completion of the growth phase. It is possible that 
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presence of these mitochondria are a sign that mitochondrial division has not been completed and 
that these oocytes are less likely to have the ability to acquire competence, a possible downfall of 
collecting oocytes from live cattle where the ability to see and selectively aspirate antral follicles 
is limited. It is possible that, since the process of recovering oocytes post mortem allows greater 
control of follicle selection than OPU does, this allows for a pool of oocytes with greater 
competence. Irregularities in mitochondrial cristae and altered morphology are associated with 
poor mitochondrial function and decreased ATP production. Given the importance of 
mitochondria in energy production, it is reasonable that oocytes with a greater number of 
irregularly shaped, budding mitochondria, are likely to have an overall decreased energy 
production. 
One reason that the success of IVM is limited is believed to be due to the fact that the 
oocytes being matured are from a heterogenous population of developmental phases at the 
initiation of culture. Although, super-stimulation provides a more homogenous follicle size at the 
time of maturation, there was no notable improvement in oocyte morphology to indicate greater 
competence. It has been proposed that one reason for this poor competence of oocytes following 
super-stimulation is that the rapid follicular growth supported by high doses of FSH causes 
asynchronous follicular growth and oocyte development (Hyttel et al., 1986; Dieleman and 
Bevers, 1993). This would result in oocytes of variable developmental levels and qualities, 
potentially including those pre-programmed for apoptosis, being exposed to a hormonal 
environment, which while stimulatory, may not enhance developmental competence. It is likely 
that the combined, abnormal hormonal environment and the stimulation of oocytes with poor 
developmental competence, combine to cause the cytoplasmic irregularities that were seen in 
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FSH oocytes in this study. It is possible that this difference has the potential to have significant 




The goal of any in vitro embryo production facility is to maximize the number of 
transferable embryos produced from each cohort of oocytes recovered. Current research in the 
field aims to maximize embryo production rates through altering the in vitro culture conditions, 
aiming to find the optimal media to increase developmental competence of oocytes and the 
resultant embryos (O'Doherty et al., 1997; Hussein et al., 2006; Balboula et al., 2010). The 
current study, instead, focuses on the innate competence of the oocyte and on attempting to 
determine the best methods of recovery to ensure that those oocytes retrieved are of the utmost 
competence at the start of the in vitro procedures. This is based on the belief that while embryo 
quality and conditions during early development are integral to pregnancy establishment, embryo 
production rates rely foremost on the intrinsic oocyte competence and oocyte handling and 
maturation conditions (Merton et al., 2003; Lonergan et al., 2006).  
As with everything else in oocyte development, the acquisition of cytoplasmic 
competence is acquired in a stepwise manner. It is understood that the first such step is the 
multiplication of organelles and the completion of mRNA and protein synthesis and their storage 
followed by the redistribution of the cytoskeleton polymers and organelles (Sirard et al., 2006a; 
Watson, 2007; Ferreira et al., 2009). Studies presented here assessed three molecular markers of 
competence; mRNA transcript abundance (section 5), IP3R1 expression (section 4), and 
cytoplasmic Ca2+ levels (section 4), the cytoskeletal marker F-actin aggregation (section 3), and 
multiple organelle markers including; mitochondria morphology and location (section 3, 4, 6), 
cortical granule location (section 6), and lipid and vesicle quantity (section 6). While there was a 
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degree in heterogeneity among all variables measured, some changes appeared to occur more 
reliably over the course of in vitro maturation than others. Similarly, some factors were easily 
affected by oocyte handling and treatment while others appeared to be resilient.  
Throughout this series of experiments, the effects of pre-maturation protocols on oocyte 
cytoplasmic maturation and competence were analyzed. In the first study, the success of the 
expected permissive effect of holding oocytes in meiotic inhibitors on cytoplasmic maturation 
completion were tested. While the meiotic inhibitors used in this study, IBMX and forskolin, 
were successful at maintaining gap junction communication between oocytes and the 
surrounding cumulus cells, this did not appear to improve cytoplasmic maturation, as measured 
by mitochondrial relocation and F-actin aggregation. Further, a decreased maturation rate was 
observed in oocytes that had been held in inhibitors prior to completing maturation. Results 
combine to suggest that rather than improving oocyte competence, this combination of meiotic 
inhibitors would be more likely to decrease total embryo production rates.  
In the second project, the aim was to assess the effects of follicular environment on 
oocyte competence. To do this, oocytes were recovered during three different follicular phases, 
(growth, peak, and atresia) with the expectation that the follicular and ovarian effects exerted on 
the oocyte population prior to collection would have significant effects on oocyte competence. 
While  the follicular phase did not impact oocyte recovery rates, or mitochondrial maturation 
parameters, it was found that oocytes collected during follicle growth showed higher levels of 
IP3R1 expression than those collected from atretic follicles. Meanwhile, while embryo 
production was unaffected by follicle growth or atresia, cytoplasmic calcium levels were 
negatively correlated with embryo production. Results indicate that there is only a slight benefit 
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to collecting oocytes from growing follicles, but that oocyte competence is correlated to calcium 
being sequestered within the endoplasmic reticulum and not free within the cytoplasm.   
In the third and fourth projects, oocytes were collected using three primary methods, 
super-stimulation, ovum pick-up and aspiration from ovaries post-mortem. Since the previous 
project failed to show a significant effect of follicular wave phase, unstimulated ovum pick-up 
was performed at random time points. Oocytes were then subjected to RNA Seq (in both GV and 
MII oocytes), transmission electron microscopy (in both GV and MII oocytes) and in vitro 
fertilization to determine the effect of oocyte retrieval method on oocyte competence dynamics. 
Overall oocytes collected following super-stimulation were most different in both ultrastructure 
and gene expression in MII oocytes. There was no significant difference in embryo development 
rates between oocytes collected following super-stimulation and those recovered post-mortem, 
but embryo development from OPU oocytes was significantly lower than that of oocytes from 
the other two recovery methods. Because of the potential lasting effects of the irregular gene 
expression and organelle dynamics in super-stimulated oocytes, it is suggested that post-mortem 
retrieved oocytes may be the most probable to be highly developmentally competent.  
Results across all three studies indicated that mitochondria in bovine oocytes do not 
undergo normal maturational parameters in vitro. Immature oocytes were recovered in all three 
experiments, and regardless of treatment, with mitochondria found in any of the described 
locations from peripheral, diffuse or clustered. While some significant interaction between 
meiotic maturation and mitochondrial progression was observed, this was incomplete and 
unaffected by attempts at delaying meiotic maturation, or by oocyte source. Mitochondria were 
also found to exhibit anomalous shapes, when viewed on transmission electron microscopy, 
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suggesting that oocytes collected and matured in vitro, regardless of collection method, may have 
incomplete mitochondrial division, resulting in impaired energy metabolism. If this effect can be 
confirmed, it may be possible that this is one of the leading reasons that in vitro embryo 
development rates are not higher, in which case further research should be aimed specifically at 
improving mitochondrial dynamics in  in vitro matured oocytes.  
Overall results suggest that use of calcium indicators is a potentially strong method of 
detecting competent oocytes, with an expectation that highly competent mature oocytes possess 
high levels of sequestered calcium, low levels of cytoplasmic calcium and high expression of 
calcium signaling receptors (such as IP3R1). Mitochondrial dynamics, on the other hand, are 
poor indicators of maturation as aberrations are frequent. Oocytes collected post-slaughter appear 
to be of the highest competence, but when performing OPU timing appears to have little effect 
on oocyte developmental ability.  
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APPENDIX. SUPPLEMENTAL MATERIALS 
  
A.1 Oocyte Grading Scheme 
A.2 Hepes-TALP 
A.3 Pre-IVM medium with FSH and IBMX 
A.4 Maturation Medium Composition 
Oocyte Grade Morphological Characteristics
A Complete enclosure with 3+ layers of cumulus cells, homogenous, dark cytoplasm with no 
granularity, small perivitelline space
B Complete enclosure with 1-2 layers of cumulus cells, dark cytoplasm perhaps with slight 
presence of granularity or vacuoles
C Partial enclosure with cumulus cells, cytoplasm may be light, irregular or containing a moderate 
degree of granularity, moderate perivitelline space
D Fragmented oocyte, or clear degeneration with with high degrees of cytoplasmic irregularities or 
discontinuous oolemma, Few to no cumulus cells associated
Component Concentration Source
Hepes TL 0.977 Caisson (IVL01)
Sodium Pyruvate 0.01 Sigma (P-4562) 2.2mg/mL stock solution
Penicillin/Streptomycin 0.01 Gibco (15140)




Hepes TALP 0.99 Stock solution described above
Forskolin 0.001 Sigma F-6886 (100µM stock solution)
IBMX 0.001 Sigma I-7018 (500µM stock solution)
Component Concentration Source
TCM-199 0.855 Sigma M4530
Fetal Bovine Serum 0.1 Cellgro 35-010-CV
Sodium Pyruvate 0.01 Sigma P-4562 (stock solution)
L-Glutamine 0.01 Sigma G-8540 (29.2mg/mL stock solution)
FSH 0.005 Bioniche (Folltropin)
EGF 0.01 (50ng/mL)
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A.5 IVF-TALP Medium 
A.6 SOF- IVC Medium 
A.7 Ionomycin Activation Medium 
Penicillin/Streptomycin 0.01 Gibco 15140
Component Concentration Source
TL-Fert 0.894 Caisson IVL02
Penicillamine/ Hypotaurine 0.04 Sigma P-4875 and H-1384 (stock solution)
Heparin 0.04 Sigma H-3149 (stock solution)
Pen/Strep 0.01 Gibco 15130
Sodium pyruvate 0.01 Sigma P-4562 (stock solution)
BSA 0.006 Sigma A-6003
Component Concentration Source
SOF 0.932 Caisson IVL05
BSA- Fatty acid free 0.003 Sigma A-6003
BME (essential amino acids) 0.02 Gibco 11140-050 100X
MEM (non-essential amino 
acids)
0.01 Gibco 11130-051 50X
Penicillin/streptomycin 0.01 Gibco 15140
Sodium pyruvate 0.02 Sigma P-4562 (stock solution)
L-Glutamine 0.005 Sigma G-8540 (stock solution)
Component Concentration Source
Step 1 (0.1mM stock);
Hepes-TALP 0.98 See above AppendixB
Ionomycin stock 0.02 Sigma I-0634 (5mM stock)
Step 2 (working solution);
Hepes-TALP 0.95 See above AppendixB
0.1mM Ionomycin 0.05 Ionomycin working solution from step 1
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A.8 DMAP activation Medium 
A.9 Hoechst Working Solution 
A.10 PBST-BSA 
Add NaOH in 5µL increments, mixing and testing pH after each addition to get a final pH of 
~7.4 
Component Concentration Source
SOF 0.99 See above Appendix F
DMAP stock 0.01 Sigma D-2629 (200mM stock)
Component Concentration Source
Hoechst stock 0.0035 Stock solution
Hepes-TALP 0.9965 Appendix B
Component Concentration Source
PBS 0.9955 Corning Cellgro 21-030-CV
BSA Fraction V 0.001 Sigma A7906
Tween 20 0.001 Sigma P1379
Phenol red 0.001 Sigma 0290
NaOH 1M ~0.15% Sigma S2770
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A.11 0.1M Phosphate Buffer pH 7.4 
A.12 Epon Resin 
Kit Supplied by EMS, product # RT 13940 contains individual bottles of each ingredient. 
*Combine first 3 ingredients by careful weight of viscous liquids. Mix well be inverting and 
store in fridge. Add DMP 30 at time of final embedding only. Always warm to room temperature 
and mix well by inverting before use. 
Component Concentration Source
Step 1: 0.2M sodium 
phosphate dibasic
Sodium phosphate dibasic 0.0276 Sigma S3264
Water 0.9724
Step 2: 0.2M sodium 
phosphate monobasic
Sodium Phosphate monobasic 0.0536 Sigma Sigma S3139
Water 0.9464
Step 3: 0.1M phosphate 
buffer
0.2M sodium phosphate 
dibasic solution
0.1 Step 1 above
0.2M sodium phosphate 
monobasic solution








A.13 Stock Solutions 
1. Dulbecco’s Phosphate Buffered Saline: Add 100 mL of 10X D-PBS solution 
(Sigma D-1283) to 900 mL of autoclaved DI water to make 1 L of D-PBS. Store at room 
temperature. Add 10 mL of Bovine Calf Serum (HyClone) and 1 mL of Heparin (Sagent 
Pharmaceuticals, Schaumburg, IL, USA) to make the D-PBS oocyte collection medium.  
2. Penicillin/Streptomycin: Gibco 15140. Aliquot ≈200 µL of new pen/strep solution 
into sterile centrifuge tubes. Store at -20°C until use.  
3. Sodium Pyruvate: Sigma P-4562. Dissolve 22 mg of sodium pyruvate in 10 mL of 
sterile Millipore-Q water to make 20mM stock solution. Sterile filter into an aluminum foil-
wrapped 15 mL conical tube and store at 4°C for up to a month.  
4. L-Glutamine: Sigma G-8540. Make a 100X stock solution with a concentration of 
20 mM by dissolving 2.92 g of glutamine in 100 mL of DI water. Aliquot 1.0 mL into sterile 
centrifuge tubes and store at -20°C.  
5. FSH: Folltropin-V (Bioniche). Make a 1000X stock solution (5 mg/mL) by 
diluting a 400 mg vial of folltropin in 80 mL of DI water. Store at -20°C in 100 µL aliquots.  
6. Forskolin: Forskolin, Sigma F-6886. Make a 10 mM stock solution by adding 244 
µL of DMSO (Sigma D-2650) to 10 mg of FSK. Aliquot 5 µL into small centrifuge tube and 
store at -20°C until use.  
7. IBMX:  3-Isobutyl-1-methylxanthine, Sigma I-7018. Prepare a 500 mM stock 
solution by adding 899 µL of DMSO (Sigma D-2650) to 100 mg of IBMX. Aliquot 5 µL into 
small centrifuge tubes and store at -20°C until use.  
8. Hyaluronidase: Sigma H-3506. Prepare a 1 mg/mL solution by dissolving 10 mg 
hyaluronidase into 10 mL of HEPES-TALP (see media formulations above). Aliquot 100 µL into 
1.5 mL sterile centrifuge tubes. Store at -80°C indefinitely.  
9. Penicillamine/Hypotaurine: Combine 5 mL of 1 mM of Hypotourine and 5 mL of 
2 mM Penicillamine to 8 mL of 0.9% saline. Aliquot into 100 µL, store at -20°C. 
10. Heparin: Dissolve H-3149 1 mg Heparin into 20 mL of 0.9% saline and filter. 
Store at -20°C 
11. BME essential amino acids: Purchased as 100X stock. Aliquot 100µL and store at 
-20°C. 
12. MEM non-essential amino acids: Purchased as 50X stock. Aliquot 200µL and 
store at -20°C. 
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13. DMAP: Add 32.63mg 6-DMAP (Sigma D-2629) to 1mL of water to make 
200mM stock solution. Heat to boiling to completely dissolve DMSO. Make aliquots of 15µL 
and store at -20°C. Aliquots will need to be heated again on thaw to re-suspend DMSO. 
14. Ionomycin: Add 1mg of Ionomycin (Sigma I-0634) to 268µL DMSO (Sigma 
D-2650) to make 5mM stock. Make 5µL aliquots and store at -20°C. 
15. Hoechst 33342: Dissolve 25 mg of Hoechst in 25 mL distilled water (1mg/mL 
stock concentration) in a 50 mL centrifuge tube. Aliquot in 1 mL microcentrifuge tubes (1 mL / 
tube). Store at -20ᵒC for several months. For working solution in embryo culture or holding 
media dilute to 1 µg/mL. 
16. Mitotracker deep red: Solubilize mitotracker powder (Molecular Probes M22426) 
by dissolving entire vial into 50µL of  DMSO (Sigma D2650). Mix 4µL of Mitotracker solution 
with 200µL of PBS. Let sit for 5 minutes in dark before use.  
17. PBS+1% BSA: Add 0.1g of BSA Fraction V  (Sigma A7906) to 10mL of PBS 
(Corning Cellgro 21-030-CV). Vortex to mix and sterile filter. (Increase to 0.2g BSA/10mL PBS 
for PBS + 2%BSA). 
18. 0.1% Triton X100: Add 5µL of Triton X100 (Sigma T9284) to 5mL of PBS 
(Corning Cellgro 21-030-CV). Triton X100 is viscous and needs to be pipetted slowly for 
precision.  
19. 4% Paraformaldehyde: Mix 2mL of 8% paraformaldehyde (Electron Microscopy 
Sciences product #157-8) with 2mL of PBS (Corning cellgro 21-030-CV). For 1% 
paraformaldehyde, mix 1mL of 8% paraformaldehyde with 7mL of PBS.  
20:Fluo3-AM: Dissolve entire tube of stain (50µg, Molecular Probes F1242) into 44µL of 
DMSO  (Sigma D2650). Mix 1µL of Fluo3-AM suspension in 49µL calcium free PBS (Corning 
cellgro 21-030-CV) to make 5µM working solutions. Make fresh at time of use. 
21: 3% Glutaraldehyde: Mix 120µL 25% glutaraldehyde (Sigma G5882) in 880µL 0.1M 
sodium phosphate buffer (appendix). Make fresh, day of use.   
22: 1% Osmium tetroxide: Dilute 4% Osmium tetroxide (Electron Microscopy Sciences 
product #19160) by adding 1mL to 3mL of 0.1M sodium phosphate buffer (appendix). Store at 
4°C. Warm fully to room temperature before use  
23: 0.5% Uranyle acetate: Dilute 1% uranyle acetate (Electron Microscopy Sciences 
product #22400-1) by adding 2mL to 2mL of sterile water. Store protected from light at 4°C. 
Warm to room temperature before use, always keeping protected from light.   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A.14 Fixation and Staining Protocol for Detecting Mitochondria and IP3R1 
Denude oocytes by vortexing for 2 minutes in 200µL of 1mg/mL hyaluronidase within a 1.7mL 
microcentrifuge tube 
Recover oocytes and rinse 3 times in Hepes-TALP 
Incubate for 30 minutes at 38.5°C in 400nM Mitotracker deep red, in a humidified chamber 
Wash 3 times for 5 minutes each in Hepes-TALP 
Incubate oocytes for 1 hour at room temperature in 4% paraformaldehyde (PFA) 
Move oocytes to 300µL fresh 1% PFA in a 1.7mL microcentrifuge tube and store at 4°C for up to 
4 weeks 
*All procedures after this point at room temperature unless otherwise noted 
** All washes should be performed on a rocking platform 
Remove oocytes from PFA, wash 3 times for 5 minutes each in PBS+1%BSA 
Incubate 30 minutes in 0.1% Triton X100 
Wash 3 times, for 5 minutes each in PBS+1%BSA 
Incubate for 2 minutes in PBST 
Wash 3 times, for 5 minutes each in PBS+1%BSA 
Block for 1 hour in PBS+2%BSA 
Incubate for 1 hour in 1° Antibody (Rabbit anti-IP3R1, 1:500)  
Wash 3 times, for 5 minutes each in PBS+1%BSA 
Incubate for 1 hours in 2° Antibody (Alexafluor 488 conjugates goat anti-rabbit IgG, 1:500) 
Wash 3 times, for 5 minutes each in PBS+1%BSA 
Mount on a clean, dry slide in minimal media under 10µL Vectashield+DAPI 
Seal slides  with clear, non-fluorescent nail polish 
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A.15 RNA-Seq Protocol 
SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing 
Oocytes were snap frozen in groups of 4 in a total volume of 2µL of PBS in an 0.5mL 
centrifuge tube 
Store samples at -80°C until time of use 
Follow protocol for Smart Seq v4 Ultra Low Input RNA Kit for Sequencing 
(ClonTech, Takara Bio USA, Mountain View CA, USA) 
A. First strand cDNA synthesis 
 Clean workspace and pipettes with alcohol followed by RNase Away 
1. Thaw 5x Ultra low first strand buffer at RT 
Thaw remaining reagents on ice 
Thaw samples on ice 
Vortex each reagent and spin down for briefly 
  
2. Prepare stock solution of 10X reaction buffer by mixing 10X Lysis Buffer with 
RNase Inhibitor 
Mix Briefly and Spin down (avoid creating bubbles) 
3. Prepare samples to a total volume of 10.5µL in individual RNase free 0.2µL PCR 
tubes 
* Control RNA concentration is 1µg/µL and needs to be diluted in nuclease-free water with 
RNase inhibitor to match the concentration of the test sample.  
Vortex gently to mix and incubate at room temperature for 5 minutes 
4. Place Samples on ice  
Component Volume
10X Lysis Buffer 19µL
RNase Inhibitor 1µL
Total 20µL
Component Negative Control Positive Control Test Sample
10X Reaction Buffer 1µL 1µL 1µL
Nuclease-Free Water 9.5µL 7.5µL 7.5µL
Diluted Control RNA* - 2 µL -
Sample - - 2µL
Total 10.5µL 10.5µL 10.5µL
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Add 2µL 3’ SMART-Seq CDS Primer II A (12µM) to each tube 
Mix well by gently vortexing and and spin tubes briefly  
5. Incubate tubes at 72°C in a pre-heated hot-lid thermal cycler for 3 minutes 
6. Prepare enough Master Mix for all reactions plus 10% of total reaction mix 
volume, at room temperature 
(This should be completed while samples are incubating in step 5) 
*SMARTScribe Reverse Transcriptase should only be added to the master mix IMMEDIATELY 
prior to use. Make master mix without SMARTScribe Reverse Transcriptase first and add this 
later when samples are ready. 
Mix well by pipetting up and down, then spin briefly 
7. Immediately after 3 minute incubation (Step 5), place samples on ice for 2 
minutes 
8. Preheat thermal cycler to 42°C 
9. Add 7.5µL Master Mix to each reaction tube 
Mix contents by gently pipetting and spin briefly 
10. Place tubes on preheated thermal cycler 
Program: 42°C 90 min 
  70°C 10 min 
  4°C forever 
Stopping point: Samples can be stored at 4°C overnight 
Component Volume
Oocytes/ Total RNA in Reaction Buffer (Table 1) 10.5µL
3’ SMART-Seq CDS Primer II A (12 µM) 2µL
Total 12.5µL
Component Volume
5X Ultra Low First-Strand Buffer 4 µL
SMART-Seq v4  Oligonucleotide (48µM) 1 µL
RNase Inhibitor (40 U/µL) 0.5 µL
SMARTScribe Reverse Transcriptase* 2µL
Total volume per reaction 5.5 µL
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B. cDNA amplification  
1. Thaw PCR reagents on ice (except for enzyme) 
Gently vortex and spin down each tube. Store on ice 
2. Prepare enough PCR Master Mix for all reactions plus 10% 
* Vortex to mix before adding DNA Polymerase. Thaw and add DNA Polymerase just prior to 
use, mix gently by pipetting. 
3. Add 30µL PCR Master Mix to each tube containing 20µL of first-strand cDNA 
product from section A 
Mix well by pipetting and spin down 
4. Place tubes in a preheated thermal cycler  
Program: 
16 cycles; 
 98°C 10s 
 65°C 30s 
 68°C 3 min 
72°C 10 min 
4°C forever  *Stopping point, tubes can be held at 4°C overnight 
C. Amplified cDNA purification 
 Bring AMPure XP bead aliquots to room temperature for at least 30 minutes, mix 
well to disperse 
 Prepare fresh 80% ethanol for each experiment (400µL per sample) 
1. Add 1µL 10X Lysis buffer to each PCR product from section B. 
2. Vortex AMPure XP beads until evenly mixed, then add 50µL of AMPure XP 
beads to each sample 
Mix thoroughly by pipetting entire volume up and down at least 10 times 
(Beads are viscous, pipette slowly) 
Incubate at room temperature for at 10-15 minutes to allow cDNA to bind beads 
Briefly spin samples 
Component Volume
2X SeqAMP PCR Buffer 25µL
PCR Primer II A (12µM) 1µL
SeqAMP DNA Polymerase* 1µL
Nuclease-Free Water 3µL
Total volume per reaction 30µL
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3. Place samples on magnetic separation device for at least 5 minutes, until liquid 
appears completely clear with no beads left in supernatant 
Keeping samples on magnetic separation device pipette supernatant and discard 
4. Keeping samples on magnetic separation device, wash beads by adding 200 µL of 
80% ethanol to each sample without disturbing beads 
Wait 30s and carefully remove and discard supernatant 
Repeat ethanol wash once more 
5. Briefly spin samples to collect liquid from sides of tube 
Place samples on magnetic separation device for 30s then remove all remaining ethanol 
with a pipette 
6. Please samples at room temperature for ~5 minutes to dry until pellet is no longer 
shiny (but before a crack appears) 
7. Add 17µL Elution Buffer to cover the bead pellet 
Remove samples from magnetic separation device and mix thoroughly to re-suspend the 
beads 
Incubate at room temperature for 5 minutes to rehydrate 
Spin briefly to collect liquid from sides of tube 
8. Place samples on magnet for 5 minutes until liquid is completely clear 
9. Transfer clear supernatant that contains cDNA from each tube to a nuclease-free, 
low-adhesion tube 
Label each tube with sample information 
Store at -20°C  *Stopping point. Samples can be stored at -20°C indefinitely 
D. Validation Using Agilent D5000 TapeStation 
1. Equilibrate D5000 reagents at room temperature for 30 minutes 
Launch the 4200 TapeStation Controller Software 
Flick D5000 screentape device to remove bubbles and load single device and loading tips 
into the 4200 TapeStation  
Vortex reagents and spin down 
2. Prepare ladder in a tube strip; 
Mix 2µL D5000 Sample Buffer and 2µL D5000 Ladder  
3. Prepare samples; 
Mix 2µL D5000 Sample Buffer and 2µL DNA sample (for each sample) 
Load samples in specific 0.2mL 8-well strip 
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Spin down then vortex using IKA vortexer (2000 rpm for 1 min) 
Spin down to position samples at bottom of tube 
4. Load samples into Agilent 4200 TapeStation Instrument  
Carefully remove caps 
Select sample positions on software  
Click Start and specify filename to save results 
E. Determine cDNA quantity using Qubit dsDNA HS Assay 
Use only Qubit assay tubes (thin-walled 0.5mL PCR tubes) 
Label on tube lids 
1. Prepare working solution by adding to each sample tube; 
198µL Qubit working solution  
2µL Sample (1µL sample/ 199µL Qubit solution if high concentration is anticipated) 
2. Make 2 standards 
190µL Qubit working solution 
10µL Qubit standard 
3. Mix both working solutions and standards by gentle pipetting 
Allow all tubes to incubate at room temperature for 2 minutes 
4. Follow instructions on Qubit Fluorometer to read standards and samples 
From home screen select DNA, dsDNA high sensitivity, read standards 
Insert tube containing Standard #1 into sample chamber close lid and press read standard 
When reading is complete remove Standard #1 
Repeat for Standard #2 
5. Press Run Samples 
On assay screen select sample volume and units 
Read each individual sample, following prompts on screen 
Top value displayed in large font on the screen is the concentration of the original sample 
Bottom value is the dilution concentration 
F. Nextera XT DNA library preparation 
Tagment Genomic DNA 
1. Based on Qubit results dilute each sample in DNase-free water to a total 
concentration of 2.5ng/µL 
2. Thaw Tagment DNA Buffer, Tagment DNA enzyme and Genomic DNA on ice 
Gently mix by inverting then spin down 
Label a new 96-well TCY plate 
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3. Save the following program on a thermal cycler lid 
Preheat lid to 55°C 
hold 55°C for 5 min 
for 10°C 
4. Add 5 µL genomic DNA (total 50ng) to each sample well on the labelled TCY 
plate 
Add 10µL of Tagment DNA Buffer to each well containing DNA 
Add 5µL of Tagment DNA Enzyme to each well containing DNA and buffer 
Pipette up and down 10x to mix 
Centrifuge at 280G for 1 minute 
5. Place on pre-programmed thermal cycler and run the program (from 3) 
6. Add 5µL of Zymo DNA binding buffer to each sample 
Incubate at room temperature for 5 minutes 
Amplify Tagmented DNA 
1. Use 2 sets of index primers so that each sample has a unique set 
Add 5µL of each index 1 down each column (A unique index #1 per column) 
Add 5µL of each index 2 across each row (A unique index #2 per row) 
Add 15µL Nextera PCR Master Mix to each sample 
Centrifugre 280G for 1 minute 
1. Place of pre-heated thermal cycler and run program; 
72°C for 3 minutes 
98°C for 30 seconds 
12 cycles; 
 95°C for 10 seconds 
 55°C for 30 seconds 
 72°C for 30 seconds 
72°C for 5 minutes 
10°C hold 
Clean up libraries 
Bring AMPure XP beads to room temperature prior to use 
Vortex AMPure XP beads 
1. Remove plate from thermal cycler and vortex 280G for 1 minute 
Transfer 50µL of PCR product from each sample to new 1.5mL tubes 
2. Add 30µL of AMPure XP beads to each sample 
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Shake at 1800 rpm for 2 minutes 
Incubate at room temperature for 5 minutes 
3. Place on magnetic stand ~2 minutes until fluid is clear 
Remove and discard supernatant 
4. Wash 2x with 200µL of fresh 80% ethanol 
Incubate for 30 seconds each time 
Remove and discard supernatant without disturbing bead pellet 
Remove residual ethanol from each well 
5. Air dry pellets on magnet for 15 minutes 
Remove from stand 
6. Add 30µL of resuspension buffer to each tube 
Shake at 1800 rpm for 2 minutes 
Incubate at room temperature for 2 minutes 
Place on magnetic stand for 2 minutes until clear 
7. Transfer 50µL of supernatant from each sample to new tubes 
Run Qubit and Agilent to verify quality 
Store at -80°C 
Pool indexed libraries 
4. Transfer 5µL from each well in column 1 of dilution plate to column 1 of pooled 
plate 
Repeat for each column of dilution plate until all samples are pooled in column 1 of 
pooled plate 
Ensure to track which samples go into which well to avoid pooling any 2 samples with 
the same index 
5. Combine the contents of each well of column 1 into well A2 of pooled plate 
Shake at 1800 rpm for 2 minutes 
6. Denature and dilute pooled libraries to a concentration of 4nM 
7. Seal plate and store at -20°C 
8. Sequence on NextSeq 500 Illumina Platform 
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A.16 Supplemental Information for RNA Seq Results 
A. Genome Alignment Reads by Treatment 
RNA-Seq results from individual samples showing the number or genes read for each sample 
and the sample genome qualities. With the exception of sample MO-3, samples were of high 











IO-1 Immature OPU 27877658 92.64 73.35 34.1
IO-2 Immature OPU 28924359 93 73.2 34.15
IO-3 Immature OPU 31806987 93 73.19 34.1
IO-4 Immature OPU 16668129 93.7 73.66 33.72
IS-1 Immature FSH 35107502 92.69 73.34 34.13
IS-2 Immature FSH 33053662 95.14 73.47 34.15
IS-3 Immature FSH 28132172 95.17 73.32 34.12
IS-4 Immature FSH 18712801 94.13 73.51 33.75
IP-1 Immature PM 24110691 91.79 73.26 33.96
IP-2 Immature PM 19172649 93.89 73.98 33.85
IP-3 Immature PM 19104861 94.64 73.99 33.75
IP-4 Immature PM 26948064 92.09 73.07 33.85
MO-1 Mature OPU 35195046 92.8 73.18 34.19
MO-2 Mature OPU 30762336 92.52 73.09 34.19
MO-3 Mature OPU 29538552 51.31 70.88 33.53
MO-4 Mature OPU 19365086 83.76 73.27 33.86
MS-1 Mature FSH 37221506 92.37 73.06 34.25
MS-2 Mature FSH 29714638 93.67 73.24 34.22
MS-3 Mature FSH 30843614 90.62 72.94 34.2
MS-4 Mature FSH 22689288 90.73 73.41 33.93
MP-1 Mature PM 18234951 93.58 73.97 33.92
MP-2 Mature PM 21268781 93.86 73.98 33.99
MP-3 Mature PM 21408228 93.98 74 33.92
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B. Heatmap of the 500 Most Variably Expressed Genes 
Figure A1. Using the hundred genes with the overall most variable expression between the six 
treatment groups, oocyte are categorized by expression on a yellow-to-orange scale with yellow 
indicating low expression and dark indicating high expression. Based on the overall pattern of 
expression for these 500 genes, oocytes are given a hierarchical ordering, seen on the right, 
indicating their similarity in gene expression patterns to each other.   
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C. Cluster Dendogram of Bovine Oocytes Based on Global Gene Expression 
Figure A2. Hierarchical relationship between bovine oocytes from different collection sources 
and maturation levels based on the global differential gene expression levels. 
D. Smear Plots Comparing Oocyte Gene Expression 
Figure A3. Smear plots comparing gene expression of oocytes between oocyte recovery 
methods, within each maturation level. Each dot on the plot indicates one gene, those in red 
having significantly different expression levels (at FDR P<0.05). Points falling outside of the 
blue indicator lines are those genes that have an expression level difference in excess of two-fold 
between the two treatments in question ( values >0 favour the first treatment listed,  those <0 






















































































































































































































































A.17 Fixation Protocol for Transmission Electron Microscopy 
Primary Fixation 
1. Fix oocytes for 1.5 hours in freshly prepared 3% glutaraldehyde at room 
temperature 
2. Transfer oocytes to a cryovial containing 0.5mL of phosphate buffer and store at 
4°C until further processing 
Agar embedding 
3. Embed oocytes in 4% agar using a stereomicroscope.  
Put oocyte in a minimal drop of phosphate buffer on a clean slide and put a drop of agar 
at 45-55°C on top of oocytes. Build up with more agar. Cool and solidify agar by placing directly 
on a dry ice pack.  
4. Cut out a small block 2x2x2mm containining each oocyte, using a razor blade  
5. Wash 2x for 5 min each in phosphate buffer, at room temperature 
Secondary, post-fixation 
6. Post-fix in 1% oxmium tetroxide for 1 hour at room temperature 
7. Wash 2x for 5 min in phosphate buffer at room temperature 
Uranyle block staining 
8. Wash 2x for 5 min each in double distilled water 
9. Stain for 1 hour in 0.5% Uranyle acetate at room temperature, in the dark 
10. Wash 2x for 5 min each in water 
Dehydration and embedding (perform incubations on a shaker plate at room temperature) 
11. Incubate 2x for 5 min each in 50% ethanol 
12. Incubate 2x for 5 min each in 70% ethanol *leave in 70% ethanol overnight 
13. Incubate 2x for 5 min each in 80% ethanol 
14. Incubate 2x for 5 min each in 90% ethanol 
15. Incubate 2x for 10 min each in 100% ethanol 
16. Incubate 2x for 5 min each in propylene oxide 
17. Incubate 1 hour in 2:1 propylene oxide: epon araldite 
18. Incubate 1 hour in 1:1 propylene oxide: epon araldite 
19. Incubate 1 hour in 1:2 propylene oxide: epon araldite 
20. Overturn tubes and dry for 30s to remove as much propylene oxide as possible 
21. Incubate overnight in epon araldite  
21. Trim away excess agar from blocks and dry blocks briefly to remove excess Epon 
and propylene oxide 
22. Embed in freshly prepared Epon+DMP 30 for 2 hours in moulds room 
temperature 
23. Replace media in moulds with fresh Epon+DMP 30, being careful to avoid 
bubbles, incubate in moulds at room temperature for 24 hours 
24. Move moulds to 37°C, incubate for 24 hours 
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25. Move moulds to 60°C, incubate for 24 hours 
26. Remove blocks from moulds 
Ultra-thin sectioning; 
27. Cut a sequence 70nm sections from each oocyte at the periphery and the 
approxiamate equator 
28. Stain sections with uranyle acetate for 15 minutes 
29. Rinse 6x for 30s each by placing sections on water droplets 
30. Stain with lead citrate for 5 min 
31. Rinse 6x for 30s each by placing sections on water droplets 
32. Gently dip sections in sterile water and blot dry 
33. Transfer sections to a copper grid for microscopy 
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